succinylcholine has been researched along with Apnea in 381 studies
Succinylcholine: A quaternary skeletal muscle relaxant usually used in the form of its bromide, chloride, or iodide. It is a depolarizing relaxant, acting in about 30 seconds and with a duration of effect averaging three to five minutes. Succinylcholine is used in surgical, anesthetic, and other procedures in which a brief period of muscle relaxation is called for.
succinylcholine : A quaternary ammonium ion that is the bis-choline ester of succinic acid.
Apnea: A transient absence of spontaneous respiration.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Safe Apnea Time was defined as the time from administration of neuromuscular blocking drugs to oxygen saturation fell to 92%." | 9.15 | Desaturation following rapid sequence induction using succinylcholine vs. rocuronium in overweight patients. ( Huang, S; Li, S; Ma, H; Tang, L; Wang, Z, 2011) |
| "6 mg/kg would allow a faster recovery of spontaneous ventilation and reduction in the incidence of hemoglobin desaturation during the period of apnea in simulated complete upper airway obstruction situations." | 9.11 | Succinylcholine dosage and apnea-induced hemoglobin desaturation in patients. ( Abdullah, K; Alharby, SW; Naguib, M; Riad, W; Samarkandi, AH, 2005) |
| " Since existing literature recommend a delay of 4 weeks and a subminimal dose of suxamethonium to prevent prolonged apnea, both these points were taken into consideration." | 8.02 | Prolonged apnea after ECT in organophosphorus poisoning - the need to redefine norms. ( Dhillon, HS; Sasidharan, S, 2021) |
| " We present a case of a 35-year-old suicidal man who developed prolonged apnea for almost 4 hours on day 13 of OP poisoning after brief general anesthesia induced by propofol and 1 mg/kg of suxamethonium, during the first session of the third cycle of modified electroconvulsive therapy, despite all due precautions." | 7.83 | Prolonged Apnea During Modified Electroconvulsive Therapy in a Patient of Suicidal Attempt by Organophosphorus Poisoning: A Case Report. ( Dhakne, R; Khairkar, P; Kumar, V; Mishra, KK, 2016) |
| "Butyrylcholinesterase deficiency is characterized by prolonged apnea after the use of muscle relaxants (suxamethonium or mivacurium) in patients who have mutations in the BCHE gene." | 7.80 | Characterization of a novel BCHE "silent" allele: point mutation (p.Val204Asp) causes loss of activity and prolonged apnea with suxamethonium. ( Bousquet, A; Ceppa, F; Delacour, H; Lockridge, O; Lushchekina, S; Mabboux, I; Masson, P; Schopfer, LM, 2014) |
| "Recombinant plant-derived butyrylcholinesterase was capable of counteracting and reversing apnea in two complementary models of lethal succinylcholine toxicity, completely preventing mortality." | 7.79 | Reversal of succinylcholine induced apnea with an organophosphate scavenging recombinant butyrylcholinesterase. ( Geyer, BC; Kannan, L; Kilbourne, J; Larrimore, KE; Mor, TS, 2013) |
| " Apnea for 45 minutes was observed after succinylcholine administration." | 7.78 | [Apnea after general anesthesia for revision of uterus in parturient with K-variant of the butyrylcholinesterase enzyme (BChE)]. ( Bahar, M; Miller-Roll, T; Negomireanu, S; Pilcha, I; Weksler, N, 2012) |
| "eleven of 13 patients with a prolonged duration of action of succinylcholine had mutations in BCHE, indicating that this is the possible reason for a prolonged period of apnea." | 7.77 | Butyrylcholinesterase gene mutations in patients with prolonged apnea after succinylcholine for electroconvulsive therapy. ( Gätke, MR; Mollerup, HM, 2011) |
| " Rarely, patients with butyrylcholinesterase deficiency may show marked sensitivity to succinylcholine, manifested clinically by severely prolonged neuromuscular paralysis and apnea." | 7.77 | Prolonged neuromuscular paralysis following rapid-sequence intubation with succinylcholine. ( Aiken, DC; Donnell, RW; Kaufman, SE; Magee, C, 2011) |
| "The best known clinical application of serum BChE assay is to predict abnormally prolonged apnea following the application of the muscle relaxant succinylcholine." | 7.74 | Determination of butyrylcholinesterase (BChE) phenotypes to predict the risk of prolonged apnea in persons receiving succinylcholine in the healthy population of western Iran. ( Aminiani, M; Kharazi, H; Kiani, A; Pourmotabbed, T; Rahimi, Z; Tavilani, H; Vaisi-Raygani, A, 2007) |
| " Thereafter prolonged apnea developed such that the patient had to be admitted to the pediatric intensive care unit." | 7.72 | [Emergency from anesthesia in small children. From laryngospasm to prolonged apnea]. ( Gries, A; Motsch, J; Springer, W; Ulmer, HE, 2003) |
| "Measurement of plasma butyrylcholinesterase (BChE) activity and inhibitor-based phenotyping are standard methods for identifying patients who experience post-succinylcholine (SC) apnea attributable to inherited variants of the BChE enzyme." | 7.72 | Butyrylcholinesterase (BCHE) genotyping for post-succinylcholine apnea in an Australian population. ( Burns, JC; Nightingale, BN; Stewart, PM; Sullivan, DR; Yen, T, 2003) |
| " During the period of apnea and as they were recovering, the volunteers received continuous verbal reassurance by the investigators." | 7.71 | Hemoglobin desaturation after succinylcholine-induced apnea: a study of the recovery of spontaneous ventilation in healthy volunteers. ( Brown, R; Caldwell, JE; Feiner, JR; Heier, T; Lin, J, 2001) |
| " A 7-h period of apnea and paralysis after administration of succinylcholine was attributed to the decreased rate of succinylcholine metabolism resulting from inhibition of pseudocholinesterase by the insecticide." | 7.71 | Prolonged apnea following succinylcholine administration in undiagnosed acute organophosphate poisoning. ( Kocamanoglu, S; Sener, EB; Tur, A; Ustun, E, 2002) |
| "8) Abnormal variants of serum cholinesterase lead to prolonged apnea." | 7.67 | [Phenotype of plasma cholinesterase in prolonged apnea and sensitivity to succinylcholine]. ( Alcalay, A; Burnat, P; Jacquot, C; Zaoui, P, 1987) |
| "A case of prolonged succinylcholine-induced paralysis in a child with organophosphate insecticide poisoning is presented." | 7.67 | Prolonged succinylcholine-induced paralysis in organophosphate insecticide poisoning. ( Curry, SC; Selden, BS, 1987) |
| "A case of prolonged apnea after administration of succinylcholine in a patient homozygous for the dibucain variant cholinesterase (genotype E1aE1a) has been presented." | 7.66 | Prolonged succinylcholine-induced apnea caused by atypical cholinesterase: report of case. ( Aston, R; Mauro, JV; Meyrowitz, MR; Smith, DB, 1980) |
| "Prolonged apnea (9 hours) after elective orthognathic surgery occurred in a healthy adult female." | 7.66 | Prolonged apnea after orthognathic surgery due to atypical cholinesterase. ( Epker, BN; O'Ryan, F, 1981) |
| " Four of these patients developed prolonged postoperative apnea; the longest period of apnea was 6 hours." | 7.66 | Prolonged postoperative apnea complicating gynecologic surgery; atypical cholinesterase and myasthenia gravis. ( Maharry, JM; Sack, RA, 1982) |
| " Safe Apnea Time was defined as the time from administration of neuromuscular blocking drugs to oxygen saturation fell to 92%." | 5.15 | Desaturation following rapid sequence induction using succinylcholine vs. rocuronium in overweight patients. ( Huang, S; Li, S; Ma, H; Tang, L; Wang, Z, 2011) |
| "To determine the effects of Magnesium-Sulphate-pretreatment on Suxamethonium-induced complications (serum potassium rise, fasciculations and apnea)." | 5.12 | The effects of magnesium sulphate-pretreatment on suxamethonium-induced complications during induction of general endotracheal anaesthesia. ( Danladi, KY; Eyelade, OR; Sotunmbi, PT, 2007) |
| "(1) To investigate changes in arterial oxygen saturation via pulse oximeter (SpO2) during apnea and after reinstitution of manual ventilation at SpO2 of 95% or 90% following rapid sequence induction of anesthesia in children after 2-minute preoxygenation; (2) to determine whether the setting of a safe threshold of apneic period to an SpO2 of 95% is appropriate in children during anesthetic induction; and (3) to evaluate the influences of age, body weight, and height on the time from the start of apnea to SpO2 of 95%." | 5.08 | Study of the safe threshold of apneic period in children during anesthesia induction. ( An, G; Deng, XM; Liao, X; Luo, LK; Tong, SY; Xue, FS, 1996) |
| ", malignant hyperthermia and prolonged apnea after succinylcholine)." | 5.05 | Personalized pediatric anesthesia and pain management: problem-based review. ( Hendrickson, M; Horn, N; Packiasabapathy, S; Rangasamy, V; Renschler, J; Sadhasivam, S, 2020) |
| " Since existing literature recommend a delay of 4 weeks and a subminimal dose of suxamethonium to prevent prolonged apnea, both these points were taken into consideration." | 4.02 | Prolonged apnea after ECT in organophosphorus poisoning - the need to redefine norms. ( Dhillon, HS; Sasidharan, S, 2021) |
| "This is a case of a 32-year-old male-to-female transgender patient with prolonged apnea following ECT treatment for severe, refractory depression." | 3.85 | Electroconvulsive Therapy Considerations for Transgendered Patients. ( Adams, DC; Balla, A; Grondin, LS; O'Donnell, SE; Tran, BK; Tsai, MH, 2017) |
| " We present a case of a 35-year-old suicidal man who developed prolonged apnea for almost 4 hours on day 13 of OP poisoning after brief general anesthesia induced by propofol and 1 mg/kg of suxamethonium, during the first session of the third cycle of modified electroconvulsive therapy, despite all due precautions." | 3.83 | Prolonged Apnea During Modified Electroconvulsive Therapy in a Patient of Suicidal Attempt by Organophosphorus Poisoning: A Case Report. ( Dhakne, R; Khairkar, P; Kumar, V; Mishra, KK, 2016) |
| " BChE deficiency induces a slower hydrolysis of the drug and consequently prolonged neuromuscular block, leading to apnea." | 3.83 | [Prolonged neuromuscular block in a patient with butyrylcholinesterase deficiency]. ( Ceppa, F; Courcelle, S; Delacour, H; Hary, B; Mabboux, I, 2016) |
| "Butyrylcholinesterase deficiency is characterized by prolonged apnea after the use of muscle relaxants (suxamethonium or mivacurium) in patients who have mutations in the BCHE gene." | 3.80 | Characterization of a novel BCHE "silent" allele: point mutation (p.Val204Asp) causes loss of activity and prolonged apnea with suxamethonium. ( Bousquet, A; Ceppa, F; Delacour, H; Lockridge, O; Lushchekina, S; Mabboux, I; Masson, P; Schopfer, LM, 2014) |
| " Apnea for 45 minutes was observed after succinylcholine administration." | 3.78 | [Apnea after general anesthesia for revision of uterus in parturient with K-variant of the butyrylcholinesterase enzyme (BChE)]. ( Bahar, M; Miller-Roll, T; Negomireanu, S; Pilcha, I; Weksler, N, 2012) |
| "eleven of 13 patients with a prolonged duration of action of succinylcholine had mutations in BCHE, indicating that this is the possible reason for a prolonged period of apnea." | 3.77 | Butyrylcholinesterase gene mutations in patients with prolonged apnea after succinylcholine for electroconvulsive therapy. ( Gätke, MR; Mollerup, HM, 2011) |
| " Rarely, patients with butyrylcholinesterase deficiency may show marked sensitivity to succinylcholine, manifested clinically by severely prolonged neuromuscular paralysis and apnea." | 3.77 | Prolonged neuromuscular paralysis following rapid-sequence intubation with succinylcholine. ( Aiken, DC; Donnell, RW; Kaufman, SE; Magee, C, 2011) |
| " Homozygotes for the A gene product are at risk for prolonged apnea following exposure to the surgical anesthetics succinylcholine or mivacurium." | 3.74 | Molecular basis of succinylcholine sensitivity in a prairie Hutterite kindred and genetic characterization of the region containing the BCHE gene. ( Coghlan, G; Mauthe, J; Triggs-Raine, B; Zelinski, T, 2007) |
| " Why did the patient have no prolonged apnea and emergence after the previous anesthesia? As the surgical time was exceeded 4 hrs, plasma suxamethonium could fortunately be less than its effective concentration at emergence." | 3.73 | [Accidental use of suxamethonium for general anesthesia in a patient with hereditary hypocholinesterasemia that was not recognized preoperatively]. ( Futagami, M; Hashimoto, H; Hirota, K; Ishihara, H; Kitayama, M; Kushikata, T; Sakai, T; Tsutaya, S; Yasujima, M, 2006) |
| " Thereafter prolonged apnea developed such that the patient had to be admitted to the pediatric intensive care unit." | 3.72 | [Emergency from anesthesia in small children. From laryngospasm to prolonged apnea]. ( Gries, A; Motsch, J; Springer, W; Ulmer, HE, 2003) |
| " On the other hand, the two methods using butyrylthiocholine as substrate and that employing benzoylcholine showed limited clinical utility in discriminating subjects at risk of prolonged apnea (area under the ROC curve < or = 0." | 3.72 | Assay using succinyldithiocholine as substrate: the method of choice for the measurement of cholinesterase catalytic activity in serum to diagnose succinyldicholine sensitivity. ( Bonora, R; Ceriotti, F; Franzini, C; Lando, G; Mosca, A; Panteghini, M; Patrosso, MC; Zaninotto, M, 2003) |
| " Thirteen out of sixteen patients tested after prolonged apnea were positive for the presence of this mutation (50." | 3.71 | Rapid identification of atypical variant of plasma butyrylcholinesterase by PCR. ( Benois, A; Burnat, P; Ceppa, F; Fontan, E; Gidenne, S, 2002) |
| " A 7-h period of apnea and paralysis after administration of succinylcholine was attributed to the decreased rate of succinylcholine metabolism resulting from inhibition of pseudocholinesterase by the insecticide." | 3.71 | Prolonged apnea following succinylcholine administration in undiagnosed acute organophosphate poisoning. ( Kocamanoglu, S; Sener, EB; Tur, A; Ustun, E, 2002) |
| "Succinylcholine and mivacurium are degraded more slowly in patients with a qualitatively or quantitatively reduced plasma cholinesterase and are therefore known for inducing a prolonged postoperative apnea." | 3.71 | [Plasma cholinesterase variations as a result of prolonged neuromuscular blockade. Review and problems encountered in two cases of prolonged neuromuscular blockade after muscle relaxation with succinylcholine as compared to mivacurium]. ( Geldner, G; Lang, C; Lukasewitz, P; Wulf, H, 2002) |
| " Conditions associated with reduced PSC activity lead to sustained action of succinylcholine and result in prolonged apnea." | 3.70 | Acquired pseudocholinesterase deficiency after high-dose cyclophosphamide. ( Chan, KW; Chiang, J; Koseoglu, V, 1999) |
| " Induction doses of ketamine 1 hour after HD exposure resulted in periods of profound apnea, with continued respiratory distress for the next 2 hours." | 3.70 | Domestic swine model for the assessment of chemical warfare agent-anesthetic interactions: some effects of sulfur mustard. ( Conley, J; Hamilton, M; Hunter, K; Lundy, P; Sawyer, TW, 2000) |
| " To the extent allowed by extrapolation from in vitro to in vivo results, this method should increase diagnostic accuracy and may directly predict duration of succinylcholine-induced apnea." | 3.67 | A new succinylcholine-based assay of plasma cholinesterase. ( Abernethy, MH; George, PM; Melton, VE, 1984) |
| "A case of prolonged succinylcholine-induced paralysis in a child with organophosphate insecticide poisoning is presented." | 3.67 | Prolonged succinylcholine-induced paralysis in organophosphate insecticide poisoning. ( Curry, SC; Selden, BS, 1987) |
| "8) Abnormal variants of serum cholinesterase lead to prolonged apnea." | 3.67 | [Phenotype of plasma cholinesterase in prolonged apnea and sensitivity to succinylcholine]. ( Alcalay, A; Burnat, P; Jacquot, C; Zaoui, P, 1987) |
| " Although the method discriminates between cholinesterase activities of drug-sensitive and nonsensitive people as well as an assay involving propionylthiocholine does, it has not revealed cholinesterase abnormalities in patients who experienced prolonged apnea after succinyldicholine, in whom no enzyme defect could be demonstrated by other procedures." | 3.67 | Is succinyldicholine the substrate of choice for the measurement of cholinesterase activity? ( Evans, RT; Faye, S, 1986) |
| "Prolonged apnea (9 hours) after elective orthognathic surgery occurred in a healthy adult female." | 3.66 | Prolonged apnea after orthognathic surgery due to atypical cholinesterase. ( Epker, BN; O'Ryan, F, 1981) |
| "A case of prolonged apnea after administration of succinylcholine in a patient homozygous for the dibucain variant cholinesterase (genotype E1aE1a) has been presented." | 3.66 | Prolonged succinylcholine-induced apnea caused by atypical cholinesterase: report of case. ( Aston, R; Mauro, JV; Meyrowitz, MR; Smith, DB, 1980) |
| " Four of these patients developed prolonged postoperative apnea; the longest period of apnea was 6 hours." | 3.66 | Prolonged postoperative apnea complicating gynecologic surgery; atypical cholinesterase and myasthenia gravis. ( Maharry, JM; Sack, RA, 1982) |
| " Bank blood transfusion prior to or during succinylcholine administration should not significantly alter the duration of action of succinylcholine, and would probably be effective in the management of prolonged apnea resulting from a deficiency of this enzyme." | 3.66 | Plasma cholinesterase activity in bank blood. ( Epstein, HM; Jarzemsky, D; Vagher, P; Zuckerman, L, 1980) |
| "Some patients present prolonged apnea following the administration of succinylcholine because of substantial portion of plasma cholinesterase (the enzyme responsible for the hydrolysis of this muscle relaxant) is present as an atypical variant." | 3.66 | [A rare case of silent cholinesterase genetic variant (author's transl)]. ( Andreu, L; Bolinches, R; Bonilla, I; Canós, I; Gil, C; Otte, A, 1980) |
| "We describe prolonged apnea following electrotherapy in a patient who was also being treated with a topical organophosphate anticholinesterase, ecothiophate iodide (phospholine iodide), for glaucoma." | 3.66 | Hazards of succinylcholine administration during electrotherapy. ( Meyer, DA; Packman, PM; Verdun, RM, 1978) |
| "Prolonged apnea after succinyldicholin is a pharmacogenetic phenomenon." | 3.65 | [Succinyldicholin sensitivity resulting from genetically determined serumcholinesterase variants]. ( Benkmann, HG; Goedde, HW; Münsch, H, 1976) |
| " Because of these reports, 23 patients with prolonged apnea after administration of succinylcholine were studied with Kalow's method for abnormal dibucaine number (DN), which characterizes this condition, and for the history of local anesthetic toxicity." | 3.65 | Survey of local anesthetic toxicity in the families of patients with atypical plasma cholinesterase. ( Eilderton, TE; Zsigmond, EK, 1975) |
| " In spontaneously breathing animals, active hyperventilation (HV) was followed by hyperpnea for up to 30 s and never by apnea." | 3.65 | Central neural stimulation of respiration in unanesthetized decerebrate cats. ( Eldridge, FL, 1976) |
| " Prolonged apnea during anesthesia from administration of succinylcholine caused by homozygosity for this gene, is expected to be extremely rare among populations of Negroes and East Asians." | 3.64 | Atypical cholinesterase gene E1a: rarity in Negroes and most Orientals. ( Morrow, A; Motulsky, AG, 1968) |
| "Morbid obesity is associated with a reduction in time to desaturate during apnoea following standard pre-oxygenation and induction of anaesthesia." | 2.70 | Effectiveness of continuous positive airway pressure to enhance pre-oxygenation in morbidly obese women. ( Berthoud, MC; Cressey, DM; Reilly, CS, 2001) |
| "A patient, with a history of cretinism, who developed suxamethonium apnoea as a consequence of a reduction in plasma cholinesterase activity secondary to the concurrence of pregnancy and liver dysfunction associated with pre-eclampsia is reported." | 1.27 | Suxamethonium apnoea associated with pregnancy and liver dysfunction in a treated cretin. ( Britten, JJ; Ferguson, A; Perriss, BW; Whittaker, M, 1983) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 291 (76.38) | 18.7374 |
| 1990's | 31 (8.14) | 18.2507 |
| 2000's | 28 (7.35) | 29.6817 |
| 2010's | 24 (6.30) | 24.3611 |
| 2020's | 7 (1.84) | 2.80 |
| Authors | Studies |
|---|---|
| Acharya, S | 1 |
| Bhattarai, S | 1 |
| Shrimanker, I | 1 |
| Gupta, SS | 1 |
| Wang, J | 1 |
| Han, X | 1 |
| Cang, J | 1 |
| Miao, C | 1 |
| Liang, C | 1 |
| Packiasabapathy, S | 1 |
| Rangasamy, V | 1 |
| Horn, N | 1 |
| Hendrickson, M | 1 |
| Renschler, J | 1 |
| Sadhasivam, S | 1 |
| Cornelius, BW | 1 |
| Jacobs, TM | 1 |
| Mintjens, N | 1 |
| Brummans, R | 1 |
| Soetens, F | 1 |
| Claes, KBM | 1 |
| Vanlinthout, LE | 1 |
| Sasidharan, S | 1 |
| Dhillon, HS | 1 |
| Millet, C | 1 |
| Plaud, B | 1 |
| Delacour, H | 3 |
| Balme, K | 1 |
| McCulloch, M | 1 |
| Stephen, C | 1 |
| Robles, A | 1 |
| Michael, M | 1 |
| McCallum, R | 1 |
| Andersson, ML | 1 |
| Møller, AM | 1 |
| Wildgaard, K | 1 |
| Geyer, BC | 1 |
| Larrimore, KE | 1 |
| Kilbourne, J | 1 |
| Kannan, L | 1 |
| Mor, TS | 1 |
| Dillon, D | 1 |
| Lee, P | 1 |
| Yuksel, E | 1 |
| Sergin, D | 1 |
| Tanatti, B | 1 |
| Alper, I | 1 |
| Zoller, M | 1 |
| Walther, S | 1 |
| Cassel, J | 1 |
| Staehr-Rye, AK | 1 |
| Nielsen, CV | 2 |
| Gätke, MR | 3 |
| Brozović, G | 1 |
| Mazul Sunko, B | 1 |
| Hafner, T | 1 |
| Bekavac, I | 1 |
| Lushchekina, S | 1 |
| Mabboux, I | 2 |
| Bousquet, A | 1 |
| Ceppa, F | 4 |
| Schopfer, LM | 1 |
| Lockridge, O | 3 |
| Masson, P | 1 |
| Thomsen, JL | 1 |
| Palmqvist, DF | 1 |
| Alvarellos, ML | 1 |
| McDonagh, EM | 1 |
| Patel, S | 1 |
| McLeod, HL | 1 |
| Altman, RB | 1 |
| Klein, TE | 1 |
| Dhakne, R | 1 |
| Mishra, KK | 1 |
| Kumar, V | 1 |
| Khairkar, P | 1 |
| Hary, B | 1 |
| Courcelle, S | 1 |
| Sellers, WF | 1 |
| Binkley, C | 1 |
| Tran, BK | 1 |
| O'Donnell, SE | 1 |
| Balla, A | 1 |
| Adams, DC | 1 |
| Grondin, LS | 1 |
| Tsai, MH | 1 |
| Kalow, W | 4 |
| Taha, SK | 1 |
| El-Khatib, MF | 1 |
| Baraka, AS | 1 |
| Haidar, YA | 1 |
| Abdallah, FW | 1 |
| Zbeidy, RA | 1 |
| Siddik-Sayyid, SM | 1 |
| Greenwood, M | 1 |
| Meechan, JG | 1 |
| Mollerup, HM | 1 |
| Dawson, JS | 1 |
| Tang, L | 1 |
| Li, S | 1 |
| Huang, S | 1 |
| Ma, H | 1 |
| Wang, Z | 1 |
| Kaufman, SE | 1 |
| Donnell, RW | 1 |
| Aiken, DC | 1 |
| Magee, C | 1 |
| Miller-Roll, T | 1 |
| Pilcha, I | 1 |
| Weksler, N | 1 |
| Negomireanu, S | 1 |
| Bahar, M | 1 |
| Sener, EB | 1 |
| Ustun, E | 1 |
| Kocamanoglu, S | 1 |
| Tur, A | 1 |
| Gidenne, S | 1 |
| Benois, A | 1 |
| Fontan, E | 1 |
| Burnat, P | 3 |
| Gries, A | 1 |
| Motsch, J | 1 |
| Ulmer, HE | 1 |
| Springer, W | 1 |
| Mosca, A | 1 |
| Bonora, R | 2 |
| Ceriotti, F | 1 |
| Franzini, C | 1 |
| Lando, G | 1 |
| Patrosso, MC | 1 |
| Zaninotto, M | 1 |
| Panteghini, M | 2 |
| Dabas, R | 1 |
| Vohra, SB | 1 |
| Yen, T | 1 |
| Nightingale, BN | 1 |
| Burns, JC | 1 |
| Sullivan, DR | 1 |
| Stewart, PM | 1 |
| FORBAT, A | 1 |
| LEHMANN, H | 5 |
| SILK, E | 4 |
| ANDERSON, HJ | 1 |
| CHURCHILL-DAVIDSON, HC | 1 |
| RICHARDSON, AT | 1 |
| NILSSON, E | 1 |
| HARRISON, BL | 1 |
| SEWARD, EH | 1 |
| SKINNER, LC | 1 |
| COWAN, KA | 1 |
| HODGES, RJ | 1 |
| HARKNESS, J | 1 |
| CALVERT, J | 1 |
| SLACK, WK | 1 |
| WIDMARK, H | 1 |
| STOVNER, J | 2 |
| LIND, B | 1 |
| JOHNSON, PD | 1 |
| ARGENT, DE | 1 |
| DINNICK, OP | 1 |
| HOBBIGER, F | 1 |
| BRENNAN, HJ | 1 |
| PALETZ, SG | 1 |
| BETTSCHART, A | 2 |
| BOVET, D | 2 |
| SCOGNAMIGLIO, W | 2 |
| GUNN, DR | 1 |
| SAMSON, HH | 1 |
| FRASCARIA, F | 2 |
| SIMMONS, PH | 1 |
| HAMELBERG, W | 1 |
| BARKER, JC | 1 |
| MAY, A | 1 |
| FILIS, CP | 1 |
| JORGENSEN, S | 1 |
| PETERSEN, H | 1 |
| LAFLEUR, F | 1 |
| VEGETO, A | 1 |
| ROSSI, E | 1 |
| ABRAMS, MW | 1 |
| GINSBERG, H | 1 |
| INCZE, F | 1 |
| CSERNOHORSZKY, V | 1 |
| AVAKIAN, AV | 1 |
| GULANIAN, KA | 1 |
| BUSH, GH | 2 |
| DOENICKE, A | 4 |
| HOLLE, F | 1 |
| FREY, HH | 1 |
| LEROY, JG | 1 |
| COLLE, JI | 1 |
| FOLDES, FF | 2 |
| LUNN, JN | 1 |
| BENZ, HG | 1 |
| GIANI, E | 1 |
| NASTRI, D | 1 |
| D'AURIA, C | 1 |
| HEIFETZ, M | 1 |
| BIRKHAN, HJ | 1 |
| SANDERSON, RE | 2 |
| CAMPBELL, D | 2 |
| LAVERTY, SG | 2 |
| KLEINE, U | 1 |
| KRAUSE, E | 1 |
| KATSURASHIMA, T | 1 |
| VICKERS, MD | 4 |
| TELFER, AB | 1 |
| MACDONALD, DJ | 1 |
| DINWOODIE, AJ | 1 |
| KELLY, M | 1 |
| LIDDELL, J | 2 |
| GOEDDE, HW | 12 |
| ALTLAND, K | 6 |
| BROSS, K | 1 |
| CROPPER, CF | 1 |
| HUGHES, M | 1 |
| BRUMLIK, J | 1 |
| MIER, M | 1 |
| PETROVICK, M | 1 |
| JENSEN, HP | 1 |
| NIXON, JC | 1 |
| THIEL, CJ | 1 |
| SFORZA, I | 1 |
| CLARKE, RS | 1 |
| DUNDEE, JW | 1 |
| DAW, RH | 1 |
| OZORIO, HP | 1 |
| HARRIS, H | 1 |
| DEBLASI, S | 1 |
| JACKSON, BG | 1 |
| GEE, EC | 1 |
| LAWS, AK | 1 |
| MCCANN, B | 1 |
| BOURKE, JR | 1 |
| MATTHEW, JR | 1 |
| CONSTAN, E | 1 |
| WHITTAKER, M | 11 |
| BAITSCH, H | 1 |
| PAVONE, G | 1 |
| ZEITLIN, GL | 1 |
| SHORT, DH | 1 |
| FIELDING, ME | 1 |
| MCCOMB, RB | 1 |
| LAMOTTA, RV | 1 |
| WETSTONE, HJ | 1 |
| BRODY, IA | 1 |
| RESNICK, JS | 1 |
| ENGEL, WK | 1 |
| DAVIDOV, S | 1 |
| KAUFMAN, L | 1 |
| KOERNER, M | 1 |
| LOTSHAW, RL | 1 |
| RUBINSTEIN, HM | 4 |
| ROSENBERG, MK | 1 |
| BOLGLA, JH | 1 |
| COHEN, BM | 1 |
| PRAKHOV, NV | 1 |
| RUDDELL, JS | 1 |
| Norris, JC | 1 |
| Barker, I | 1 |
| Harle, CC | 1 |
| McKendrick, R | 1 |
| Goodall, R | 1 |
| Strock, D | 1 |
| Kuczkowski, KM | 1 |
| Greenberg, M | 1 |
| Naguib, M | 1 |
| Samarkandi, AH | 1 |
| Abdullah, K | 1 |
| Riad, W | 1 |
| Alharby, SW | 1 |
| Kenane, N | 1 |
| Chellak, S | 1 |
| Bigaillon, C | 1 |
| El-Orbany, MI | 1 |
| Joseph, NJ | 2 |
| Salem, MR | 2 |
| Alexander, R | 1 |
| Fardell, S | 1 |
| Hashimoto, H | 1 |
| Kushikata, T | 1 |
| Kitayama, M | 1 |
| Ishihara, H | 1 |
| Hirota, K | 1 |
| Sakai, T | 1 |
| Futagami, M | 1 |
| Yasujima, M | 1 |
| Tsutaya, S | 1 |
| Zelinski, T | 1 |
| Coghlan, G | 1 |
| Mauthe, J | 1 |
| Triggs-Raine, B | 1 |
| Vaisi-Raygani, A | 2 |
| Rahimi, Z | 1 |
| Kharazi, H | 1 |
| Tavilani, H | 1 |
| Aminiani, M | 1 |
| Kiani, A | 1 |
| Pourmotabbed, T | 1 |
| Karmarkar, A | 1 |
| DeMello, W | 1 |
| Danladi, KY | 1 |
| Sotunmbi, PT | 1 |
| Eyelade, OR | 1 |
| De Jong, RH | 1 |
| Wagman, IH | 1 |
| Prince, DA | 1 |
| Theodore, J | 1 |
| Millen, JE | 1 |
| Murdaugh, HV | 1 |
| Robin, ED | 1 |
| Clancy, J | 1 |
| Vanderhoof, E | 1 |
| Campbell, P | 1 |
| Himes, JA | 1 |
| Edds, GT | 1 |
| Kirkham, WW | 1 |
| Neal, FC | 1 |
| Nolan, RT | 1 |
| Anderson, KS | 1 |
| Kendall, JD | 1 |
| Abernethy, MH | 1 |
| George, PM | 1 |
| Melton, VE | 1 |
| Chautard-Freire-Maia, EA | 1 |
| Carvalho, RD | 1 |
| da Silva, MC | 1 |
| Souza, MG | 1 |
| Azevedo, ES | 1 |
| Deam, D | 1 |
| Emmanuel, ER | 1 |
| Bevan, DR | 1 |
| Donati, F | 1 |
| Galley, RL | 1 |
| O'Ryan, F | 1 |
| Epker, BN | 1 |
| Owen, H | 1 |
| Hunter, AR | 4 |
| Oshita, S | 1 |
| Sari, A | 1 |
| Fujii, S | 1 |
| Yonei, A | 1 |
| Ferguson, A | 1 |
| Britten, JJ | 1 |
| Perriss, BW | 1 |
| Meyrowitz, MR | 1 |
| Mauro, JV | 1 |
| Aston, R | 1 |
| Smith, DB | 1 |
| Datta, S | 1 |
| Alper, MH | 1 |
| Brown, SS | 3 |
| Pilz, W | 3 |
| Woronick, CL | 1 |
| Moore, DC | 1 |
| Morgan, AA | 2 |
| Gabrielsen, J | 1 |
| Valentin, N | 1 |
| Valle Sánchiz, J | 1 |
| Herraiz Domínguez, V | 1 |
| Gracia Vidal, C | 1 |
| Botello Aguado, C | 1 |
| Ascorve Domínquez, A | 1 |
| Maharry, JM | 1 |
| Sack, RA | 1 |
| Jackson, SH | 1 |
| Bailey, GW | 1 |
| Stevens, G | 1 |
| Chung, SJ | 1 |
| Andrews, D | 1 |
| Mohandas, K | 1 |
| Sivaneswaran, N | 2 |
| Inbasegaran, K | 1 |
| Epstein, HM | 1 |
| Jarzemsky, D | 1 |
| Zuckerman, L | 1 |
| Vagher, P | 1 |
| Evans, RT | 6 |
| Iqbal, J | 1 |
| Dietz, AA | 4 |
| Lubrano, T | 3 |
| Alvarez Gómez, JA | 2 |
| Alvarez Ossorio, R | 2 |
| Aguilar Alenda, R | 1 |
| Lozano Tonkin, E | 1 |
| López López, H | 1 |
| Rosa Riquelme, M | 1 |
| Bernal García, G | 1 |
| Díaz Cayuela, A | 1 |
| Pérez Guillermo, F | 2 |
| Button, C | 1 |
| Bertschinger, HJ | 1 |
| Mülders, MS | 1 |
| Jayasuriya, JP | 1 |
| Lanks, KW | 1 |
| Sklar, GS | 1 |
| MacDonald, R | 1 |
| Robinson, A | 1 |
| El-Hawary, KA | 1 |
| El-Kateb, HM | 1 |
| Hussein, SM | 1 |
| Atallah, MD | 1 |
| Otte, A | 2 |
| Bonilla, I | 1 |
| Gil, C | 2 |
| Bolinches, R | 2 |
| Andreu, L | 2 |
| Canós, I | 1 |
| Wroe, JM | 1 |
| Viby-Mogensen, J | 5 |
| Pasquariello, CA | 2 |
| Schwartz, RE | 2 |
| Jensen, FS | 1 |
| Vassallo, SA | 1 |
| Goudsouzian, NG | 1 |
| Mitchell, JB | 1 |
| Harrop-Griffiths, W | 1 |
| Roux, A | 1 |
| Ansermino, JM | 1 |
| Taylor, A | 1 |
| McCarroll, M | 1 |
| Frawley, GP | 1 |
| Carden, JR | 1 |
| Stone, RJ | 1 |
| Smith, DC | 2 |
| Ridley, SA | 1 |
| Donaldson, KF | 1 |
| Davidson, A | 1 |
| Brown, TC | 1 |
| Blanloeil, Y | 1 |
| Delaroche, O | 1 |
| Tequi, B | 1 |
| Gunst, JP | 1 |
| Dixneuf, B | 1 |
| Xue, FS | 1 |
| Luo, LK | 1 |
| Tong, SY | 1 |
| Liao, X | 1 |
| Deng, XM | 1 |
| An, G | 1 |
| Aguilar-Aguilar, G | 1 |
| Aguilar-Olmos, JM | 1 |
| Gil-Minguillón, C | 1 |
| Gómez-Casals, V | 1 |
| Rodríguez-Camps, S | 1 |
| Michel, D | 1 |
| Simon, L | 1 |
| Garbay, MM | 1 |
| Sacquin, P | 1 |
| Hamza, J | 1 |
| Saint-Maurice, C | 1 |
| Baraka, A | 2 |
| Davies, P | 1 |
| Landy, M | 1 |
| Simeon-Rudolf, V | 1 |
| Kovarik, Z | 1 |
| Skrinjarić-Spoljar, M | 1 |
| Carrión Pareja, JC | 1 |
| Candel Calderón, M | 1 |
| Orcastegui, JL | 1 |
| Ho, VW | 1 |
| Osiovich, H | 1 |
| Koseoglu, V | 1 |
| Chiang, J | 1 |
| Chan, KW | 1 |
| McLoughlin, L | 1 |
| Conley, J | 1 |
| Hunter, K | 1 |
| Lundy, P | 1 |
| Hamilton, M | 1 |
| Sawyer, TW | 1 |
| Heier, T | 1 |
| Feiner, JR | 1 |
| Lin, J | 1 |
| Brown, R | 1 |
| Caldwell, JE | 1 |
| Cressey, DM | 1 |
| Berthoud, MC | 1 |
| Reilly, CS | 1 |
| Kopman, AF | 1 |
| Adnet, F | 1 |
| Borron, SW | 1 |
| Lapostolle, F | 1 |
| Boeck, AT | 1 |
| Fry, DL | 1 |
| Sastre, A | 1 |
| Lang, C | 1 |
| Lukasewitz, P | 1 |
| Wulf, H | 1 |
| Geldner, G | 1 |
| Bach, PH | 1 |
| Wingfield, ES | 1 |
| Leary, WP | 1 |
| Bach, F | 1 |
| Turner, H | 1 |
| King, J | 3 |
| Canos, J | 1 |
| Rogla, F | 1 |
| Agarwal, DP | 3 |
| Schwenkenbecher, S | 1 |
| Srivastava, LM | 2 |
| Poulton, TJ | 1 |
| James, FM | 1 |
| Hanel, HK | 5 |
| Hansen, E | 1 |
| Graae, J | 1 |
| Gerosky, T | 1 |
| O'Leary, J | 1 |
| Hunt, R | 1 |
| Hutchinson, MA | 1 |
| Keller, H | 1 |
| Müller, R | 1 |
| Hutter, CD | 1 |
| McQueen, MJ | 2 |
| Lepinskie, F | 1 |
| Strickland, RD | 1 |
| Trimble, A | 1 |
| Candy, JJ | 1 |
| Packman, PM | 1 |
| Meyer, DA | 1 |
| Verdun, RM | 1 |
| Roglá Benedito, F | 1 |
| Corcuera Linares, F | 1 |
| Andreu Miquel, L | 1 |
| Canos Llacer, I | 1 |
| Bolinches Bolinches, R | 1 |
| Avery, D | 1 |
| Finn, R | 1 |
| Scholler, KL | 4 |
| Benkmann, HG | 2 |
| Chan, CS | 1 |
| Robinson, JD | 1 |
| Lam, KT | 1 |
| Stadskleiv, K | 1 |
| Mogensen, JV | 2 |
| Münsch, H | 2 |
| Dewar, FM | 1 |
| Wakefield, G | 1 |
| Zsigmond, EK | 3 |
| Eilderton, TE | 2 |
| Precious, DS | 1 |
| Kuriyama, K | 1 |
| Price, EM | 1 |
| Guarneri, G | 1 |
| Caporali, C | 1 |
| Savoldi, R | 1 |
| Haroun, S | 1 |
| Bassili, M | 1 |
| Abu-Haider, G | 1 |
| Pronk, IR | 1 |
| van der Wal, SJ | 1 |
| Thé, TH | 1 |
| Berry, M | 1 |
| Das, PK | 1 |
| Eldridge, FL | 1 |
| Pannall, PR | 1 |
| Potgieter, GM | 1 |
| Raubenheimer, MM | 1 |
| Benzer, A | 1 |
| Luz, G | 1 |
| Oswald, E | 1 |
| Schmoigl, C | 1 |
| Menardi, G | 1 |
| Huang, JS | 1 |
| Talbot, AR | 1 |
| Chen, CL | 1 |
| Gill, RS | 1 |
| O'Connell, N | 1 |
| Scott, RP | 1 |
| Walker, L | 1 |
| Griffiths, D | 1 |
| Earl, P | 1 |
| Fridliand, MI | 1 |
| Zinevich, VP | 1 |
| Clarke, C | 1 |
| Lindsay, RG | 1 |
| Mets, B | 1 |
| Woolf, BH | 1 |
| Selden, BS | 1 |
| Curry, SC | 1 |
| Velin, P | 1 |
| Dupont, D | 1 |
| Lainé-Cessac, P | 1 |
| Turcant, A | 1 |
| Allain, P | 1 |
| Weeks, DB | 1 |
| Ford, D | 1 |
| Ritter, DM | 1 |
| Rettke, SR | 1 |
| Ilstrup, DM | 1 |
| Burritt, MF | 2 |
| Pagani, F | 1 |
| Martinez Pretel, CM | 1 |
| Tarín Royo, F | 1 |
| Peña Macias, MJ | 1 |
| Vidal, CJ | 1 |
| Jacquot, C | 1 |
| Alcalay, A | 1 |
| Zaoui, P | 1 |
| Mehta, Y | 1 |
| Hole, P | 1 |
| Faye, S | 1 |
| Nelson, TC | 1 |
| Sapsford, DJ | 1 |
| Barkai, AI | 1 |
| Barrie, H | 1 |
| Miller, G | 1 |
| Gualandi, W | 2 |
| Bonfanti, G | 1 |
| Magbagbeola, JA | 1 |
| Lemaire, WJ | 1 |
| Nagel, EL | 1 |
| Smith, JC | 2 |
| Gibb, DB | 1 |
| Katz, RL | 1 |
| Gissen, AJ | 1 |
| Benatar, SR | 1 |
| Figueroa, M | 1 |
| Weis, KH | 1 |
| Bauld, HW | 1 |
| Gibson, PF | 2 |
| Jebson, PJ | 1 |
| Markoff, N | 1 |
| Ernst, FW | 1 |
| Poweleit, AC | 1 |
| Walker, IR | 1 |
| Zapf, PW | 1 |
| Mackay, IR | 1 |
| Kimbrough, RD | 2 |
| Suggs, JE | 2 |
| Cohen, SN | 1 |
| Weber, WW | 1 |
| Foley, EI | 1 |
| Walton, B | 1 |
| Savege, TM | 1 |
| Strunin, L | 1 |
| Simpson, BR | 1 |
| Whitford, JH | 1 |
| Cory, CE | 1 |
| Beddard, JB | 1 |
| Rosalki, SB | 1 |
| Davidson, WS | 1 |
| Pembrey, ME | 1 |
| Griffin, D | 1 |
| Subrahmanyam, HS | 1 |
| Micheli, A | 1 |
| Rink, RA | 1 |
| Husain, M | 1 |
| Purry, NA | 1 |
| Jardine, WI | 1 |
| Ferguson, AS | 1 |
| Sinton, RI | 1 |
| Happle, R | 1 |
| Lubin, AH | 1 |
| Garry, PJ | 2 |
| Owen, GM | 1 |
| Horne, J | 1 |
| Watson, TD | 1 |
| Giesecke, AH | 1 |
| Raj, PR | 1 |
| Ahlgren, EW | 1 |
| Nelson, RA | 1 |
| Miller, T | 1 |
| Miguel Martínez, J | 1 |
| Miguel Magro, E | 1 |
| McStravog, LJ | 1 |
| Richardson, RB | 1 |
| Derrick, WS | 1 |
| Prince, LC | 1 |
| Notari, RE | 1 |
| Jenkins, AV | 1 |
| Sammons, HG | 1 |
| Goedee, HW | 1 |
| Mone, JG | 1 |
| Mathie, WE | 1 |
| Simpson, NE | 1 |
| Schloot, W | 1 |
| Peck, AW | 1 |
| Wildsmith, JA | 1 |
| Garner, M | 1 |
| Rubinstein, H | 1 |
| Varma, YS | 1 |
| Sharma, PL | 1 |
| Singh, HW | 1 |
| Wulfsohn, NL | 1 |
| Fishtal, A | 1 |
| Chapman, CN | 1 |
| Baer, G | 1 |
| Avery, WG | 1 |
| Sackner, MA | 1 |
| Bourne, JG | 1 |
| Dal Prato, G | 1 |
| Magni, E | 1 |
| Pascale, M | 1 |
| Pasini, G | 1 |
| Short, CE | 1 |
| Cuneio, J | 1 |
| Cupp, D | 1 |
| Bellucci, G | 1 |
| La Cour, D | 1 |
| Juul-Jensen, P | 1 |
| Reske-Nielsen, E | 1 |
| McLellan, GH | 1 |
| Billings, JD | 1 |
| Chasapakis, G | 2 |
| Dimas, C | 1 |
| Augustaki, O | 1 |
| Kekis, N | 1 |
| Philippou, P | 1 |
| Moraitis, H | 1 |
| Floras, A | 1 |
| Makkous, A | 1 |
| Seybold, R | 2 |
| Bräutigam, KH | 2 |
| Gesing, H | 1 |
| Krumey, I | 2 |
| Schmidinger, S | 2 |
| Carson, SA | 1 |
| Chorley, GE | 1 |
| Hamilton, FN | 1 |
| Lee, DC | 1 |
| Morris, LE | 1 |
| Martínez Hernández, A | 1 |
| Jacobson, A | 1 |
| Hankla, I | 1 |
| Soshnikov, EI | 1 |
| Durinian, RA | 1 |
| Safonov, VA | 1 |
| Cohen, PJ | 1 |
| Reynolds, RC | 1 |
| Naidl, J | 1 |
| Hazel, B | 1 |
| Monier, D | 1 |
| Trempe, L | 1 |
| Beauchemin, M | 1 |
| Rondeau, Y | 1 |
| Castles, TR | 1 |
| Loth, E | 1 |
| Crawford, CR | 1 |
| Lee, CC | 1 |
| Don, HF | 1 |
| Wahba, M | 1 |
| Cuadrado, L | 1 |
| Kelkar, K | 1 |
| Litwiller, RW | 1 |
| Ross, DM | 1 |
| Morgan, HG | 1 |
| Morillo Conejo, A | 1 |
| Gasco García, MC | 1 |
| Cirac Andreu, L | 1 |
| Vetten, KB | 1 |
| Rex, MA | 1 |
| Downs, JR | 1 |
| Hörlein, H | 2 |
| Bimonte, D | 1 |
| Merola, L | 1 |
| Serra, E | 1 |
| Susini, F | 1 |
| Oda, M | 1 |
| Patané, S | 1 |
| Bellelli, M | 1 |
| Russo, S | 1 |
| Arcerito, S | 1 |
| Motulsky, AG | 1 |
| Morrow, A | 1 |
| Farrar, CH | 1 |
| Powell, BJ | 1 |
| Martin, LK | 1 |
| Cherniack, NS | 1 |
| Longobardo, GS | 1 |
| Palermo, FP | 1 |
| Heymann, M | 1 |
| Zoerb, DL | 1 |
| Robertson, GS | 1 |
| Hains, J | 1 |
| Brodeur, J | 1 |
| Martin, P | 1 |
| Authier, L | 1 |
| Lebel, E | 1 |
| Pitts, FN | 1 |
| Woodruff, RA | 1 |
| Craig, AG | 1 |
| Rich, CL | 1 |
| Sonnino, S | 1 |
| Funke, LA | 1 |
| La Marra, C | 1 |
| Marrollo, E | 1 |
| Fantera, A | 1 |
| Simon, NM | 1 |
| Del Greco, F | 1 |
| Bodley, PO | 1 |
| Halwax, K | 1 |
| Potts, L | 1 |
| Walker, JA | 1 |
| Artz, CP | 1 |
| Guillet, GG | 1 |
| Craig, HV | 1 |
| Demeester, P | 1 |
| Bettex, M | 2 |
| Schärli, A | 2 |
| Pallini, C | 1 |
| Saba, GM | 1 |
| Sandoli, A | 1 |
| Tigano, U | 1 |
| Grohmann, W | 1 |
| Sato, M | 1 |
| Köhler, H | 1 |
| Szeinberg, A | 1 |
| Pipano, S | 1 |
| Ostfeld, E | 1 |
| Impastato, DJ | 1 |
| Gesztes, T | 1 |
| Thompson, JC | 1 |
| Leacock, AM | 1 |
| Campbell, DJ | 1 |
| McIntyre, JW | 1 |
| Madill, MF | 1 |
| Vandewater, SL | 1 |
| Lavoie, G | 1 |
| List, WF | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| "A Less-rapid Sequence Anesthetic Induction/Intubation Sequence? Does Apneic Oxygenation by Means of an Oxygenating Laryngoscope Blade Prolong the Duration of Apnea Without Desaturation in Paralyzed Non-obese and Morbidly Obese Patients?"[NCT02943629] | 0 participants (Actual) | Interventional | 2016-11-30 | Withdrawn (stopped due to Lack of feasibility) | |||
| Preoxygenation With Optiflow™, a High Flow Nasal Cannula (HFNC), is Superior to Preoxygenation With Facemask in Morbidly Obese Patients Undergoing General Anesthesia[NCT03009877] | 0 participants (Actual) | Interventional | 2018-07-31 | Withdrawn (stopped due to withdrawn prior to IRB approval) | |||
| Apneic Oxygenation With a Nasal Cannula in the Obese and Morbidly Obese Surgical Patient: A Randomized, Double-Blinded, Placebo-Controlled Trial[NCT03671837] | 135 participants (Actual) | Interventional | 2017-07-12 | Completed | |||
| EPO2-A: Evaluation of Different Pre-Oxygenation Condition in Morbid Obesity: Effect of Position and Positive Pressure Ventilation During General Anesthesia Induction[NCT02590406] | 50 participants (Actual) | Interventional | 2015-09-30 | Completed | |||
| Effect of Intravenous Infusion of Magnesium Sulfate Associated or Not to Lidocaine On the Neuromuscular Blockade Induced by Muscle Relaxant Cistracurium[NCT02483611] | Phase 4 | 48 participants (Actual) | Interventional | 2015-07-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Evaluation of the maximum expired oxygen fraction obtained in the two groups (NCT02590406)
Timeframe: After 3 minutes of pre-oxygenation
| Intervention | Maximum expired fraction of oxygen obtai (Mean) |
|---|---|
| Beach Chair (BC) and ZEEP | 0.89 |
| Reverse Trendelenburg and NIPPV | 0.91 |
Evaluation of the minimal saturation obtained after the resumption of the ventilation (NCT02590406)
Timeframe: After the end of the Non-hypoxic apnea time
| Intervention | percent (Mean) |
|---|---|
| Beach Chair (BC) and ZEEP | 83.6 |
| Reverse Trendelenburg and NIPPV | 85.3 |
Change of Non-hypoxic apnea time in obese patient during a General Anesthesia induction, as a result of different pre-oxygenation position and ventilation mode; 1-Beach Chair and No positive pressure ventilation, 2-Reverse Trendelenburg and positive pressure ventilation and PEEP. End of measure time frame is 5 minutes after intubation (NCT02590406)
Timeframe: After a 3 minutes pre-oxygenation period
| Intervention | seconds (Mean) |
|---|---|
| Beach Chair (BC) and ZEEP | 216.7 |
| Reverse Trendelenburg and NIPPV | 258.2 |
(NCT02590406)
Timeframe: Evaluation of the time needed to the beginning of the ventilation to the moment where the saturation is 97%
| Intervention | seconds (Mean) |
|---|---|
| Beach Chair (BC) and ZEEP | 88.4 |
| Reverse Trendelenburg and NIPPV | 68 |
Evaluation of time needed to obtain an expired fraction of oxygen of > 0,9 in the two groups during the pre-oxygenation (NCT02590406)
Timeframe: During the pre-oxygenation period
| Intervention | seconds (Mean) |
|---|---|
| Beach Chair (BC) and ZEEP | 145.3 |
| Reverse Trendelenburg and NIPPV | 85.1 |
"The clinical duration is the elapsed time for T1 recovery = 25% (Dur25%) of the original value of T1 after the infusion of cisatracurium.~This outcome meansure was presented in minutes." (NCT02483611)
Timeframe: Participants were followed during the anesthetic - surgical procedure, an average of 90 minutes
| Intervention | minutes (Median) |
|---|---|
| Group M | 82.68 |
| Group ML | 86.33 |
| Group C | 64.8 |
"The final recovery index is the elapsed time between the T1 recovery = 25% (Dur25%) and T4 / T1 = 80% (TOF = 80%) after the infusion of cisatracurium.~This outcome measure was presented in minutes." (NCT02483611)
Timeframe: Participants were followed during the anesthetic - surgical procedure, an average of 90 minutes
| Intervention | minutes (Mean) |
|---|---|
| Group M | 27.97 |
| Group ML | 33.81 |
| Group C | 21.51 |
In the operating room, patients were cardiovascular, respiratory and body temperature monitored through the Dixtal 2020. The measure of heart rate was recorded and annotated at various times such as in the arrival of the patient in the operating room. This time point was named as moment '1'. (NCT02483611)
Timeframe: This measure of heart rate was performed when the patient arrived in the operating room
| Intervention | beats/min (Mean) |
|---|---|
| Group M | 79.94 |
| Group ML | 77.25 |
| Group C | 73.66 |
In the operating room, patients were cardiovascular, respiratory and body temperature monitored through the Dixtal 2020. The heart rate was recorded and annotated at various times such as in the moment immediately before the anesthesia induction. This time point was named as moment '2'. (NCT02483611)
Timeframe: This measure of heart rate was performed immediately before induction of anesthesia
| Intervention | beats/min (Mean) |
|---|---|
| Group M | 74.69 |
| Group ML | 73.69 |
| Group C | 75.40 |
In the operating room, patients were cardiovascular, respiratory and body temperature monitored through the Dixtal 2020. The heart rate was recorded and annotated at various times such as immediately before the start of the infusion of the solution X (magnesium sulfate or isotonic solution) and Y solution (lidocaine or isotonic solution). This time point was named as moment '3'. (NCT02483611)
Timeframe: This measure of heart rate was performed immediately before the start of the infusion of the solution X (magnesium sulfate or isotonic solution) and Y solution (lidocaine or isotonic solution)
| Intervention | beats/min (Mean) |
|---|---|
| Group M | 72.94 |
| Group ML | 74.19 |
| Group C | 75.40 |
In the operating room, patients were cardiovascular, respiratory and body temperature monitored through the Dixtal 2020. The heart rate was recorded and annotated at various times such as in the end of the study solutions infusion. This time point was named as moment '4'. (NCT02483611)
Timeframe: This measure of heart rate was performed five minutes after M3 (in the end of the X and Y solutions infusion)
| Intervention | beats/min (Mean) |
|---|---|
| Group M | 71.94 |
| Group ML | 72.25 |
| Group C | 65.07 |
In the operating room, patients were cardiovascular, respiratory and body temperature monitored through the Dixtal 2020. The heart rate was recorded and annotated at various times such as immediately before the tracheal intubation. This time point was named as moment '5'. (NCT02483611)
Timeframe: This measure of heart rate was performed immediately before the tracheal intubation
| Intervention | beats/min (Mean) |
|---|---|
| Group M | 67.56 |
| Group ML | 69.31 |
| Group C | 64.27 |
In the operating room, patients were cardiovascular, respiratory and body temperature monitored through the Dixtal 2020. The heart rate was recorded and annotated at various times such as one minute after the tracheal intubation. This time point was named as moment '6'. (NCT02483611)
Timeframe: This measure of heart rate was performed one minute after the tracheal intubation
| Intervention | beats/min (Mean) |
|---|---|
| Group M | 66.50 |
| Group ML | 68.19 |
| Group C | 65.13 |
In the operating room, patients were cardiovascular, respiratory and body temperature monitored through the Dixtal 2020. The heart rate was recorded and annotated at various times such as 15 minutes after the traqueal intubation.This time point was named as moment '7a'. (NCT02483611)
Timeframe: This measure of heart rate was performed 15 minutes after the traqueal intubation
| Intervention | beats/min (Mean) |
|---|---|
| Group M | 68.94 |
| Group ML | 68.19 |
| Group C | 67.13 |
In the operating room, patients were cardiovascular, respiratory and body temperature monitored through the Dixtal 2020. The heart rate was recorded and annotated at various times such as 30 minutes after the traqueal intubation. This time point was named as moment '7b'. (NCT02483611)
Timeframe: This measure of heart rate was performed 30 minutes after the traqueal intubation
| Intervention | beats/min (Mean) |
|---|---|
| Group M | 67.44 |
| Group ML | 68.38 |
| Group C | 64.00 |
In the operating room, patients were cardiovascular, respiratory and body temperature monitored through the Dixtal 2020. The heart rate was recorded and annotated at various times such as 45 minutes after the traqueal intubation. This time point was named as moment '7c'. (NCT02483611)
Timeframe: This measure of heart rate was performed 45 minutes after the traqueal intubation
| Intervention | beats/min (Mean) |
|---|---|
| Group M | 65.75 |
| Group ML | 65.75 |
| Group C | 62.33 |
In the operating room, patients were cardiovascular, respiratory and body temperature monitored through the Dixtal 2020. The heart rate was recorded and annotated at various times such as 60 minutes after the traqueal intubation. This time point was named as moment '7d'. (NCT02483611)
Timeframe: This measure of heart rate was performed 60 minutes after the traqueal intubation
| Intervention | beats/min (Mean) |
|---|---|
| Group M | 66.19 |
| Group ML | 65.31 |
| Group C | 61.93 |
In the operating room, patients were cardiovascular, respiratory and body temperature monitored through the Dixtal 2020. The heart rate was recorded and annotated at various times such as 75 minutes after the traqueal intubation. This time point was named as moment '7e'. (NCT02483611)
Timeframe: This measure of heart rate was performed 75 minutes after the traqueal intubation
| Intervention | beats/min (Median) |
|---|---|
| Group M | 66.50 |
| Group ML | 63.00 |
| Group C | 58.00 |
In the operating room, patients were cardiovascular, respiratory and body temperature monitored through the Dixtal 2020. The heart rate was recorded and annotated at various times such as 90 minutes after the traqueal intubation. This time point was named as moment '7f'. (NCT02483611)
Timeframe: This measure of heart rate was performed 90 minutes after the traqueal intubation
| Intervention | beats/min (Median) |
|---|---|
| Group M | 66.00 |
| Group ML | 61.00 |
| Group C | 61.00 |
"The latency is computed as the elapsed time to reduce the response of T1 to 5% of the initial contraction force after the infusion of cisatracurium.~This outcome meansure was presented in seconds." (NCT02483611)
Timeframe: Participants were followed during the anesthetic - surgical procedure, an average of 90 minutes
| Intervention | seconds (Mean) |
|---|---|
| Group M | 139.70 |
| Group ML | 151.30 |
| Group C | 147.80 |
In the operating room, patients were cardiovascular, respiratory and body temperature monitored through the Dixtal 2020. The mean blood pressure was recorded and annotated at various times such as in the arrival of the patient in the operating room. This time point was named as moment '1'. (NCT02483611)
Timeframe: This measure of average blood pressure was performed when the patient arrived in the operating room
| Intervention | mmHg (Mean) |
|---|---|
| Group M | 94.63 |
| Group ML | 88.75 |
| Group C | 100.10 |
In the operating room, patients were cardiovascular, respiratory and body temperature monitored through the Dixtal 2020. The mean blood pressure was recorded and annotated at various times such as in the moment immediately before the anesthesia induction. This time point was named as moment '2'. (NCT02483611)
Timeframe: This measure of average blood pressure was performed immediately before induction of anesthesia
| Intervention | mmHg (Mean) |
|---|---|
| Group M | 87.63 |
| Group ML | 84.69 |
| Group C | 92.47 |
In the operating room, patients were cardiovascular, respiratory and body temperature monitored through the Dixtal 2020. The mean blood pressure was recorded and annotated at various times such as immediately before the start of the infusion of the solution X (magnesium sulfate or isotonic solution) and Y solution (lidocaine or isotonic solution). This time point was named as moment '3'. (NCT02483611)
Timeframe: This measure of average blood pressure was performed immediately before the start of the infusion of the solution X (magnesium sulfate or isotonic solution) and Y solution (lidocaine or isotonic solution)
| Intervention | mmHg (Mean) |
|---|---|
| Group M | 75.88 |
| Group ML | 73.88 |
| Group C | 76.73 |
In the operating room, patients were cardiovascular, respiratory and body temperature monitored through the Dixtal 2020. The mean blood pressure was recorded and annotated at various times such as in the end of the study solutions infusion.This time point was named as moment '4'. (NCT02483611)
Timeframe: This measure of average blood pressure was performed five minutes after M3 (in the end of the X and Y solutions infusion)
| Intervention | mmHg (Median) |
|---|---|
| Group M | 69.00 |
| Group ML | 63.00 |
| Group C | 74.00 |
In the operating room, patients were cardiovascular, respiratory and body temperature monitored through the Dixtal 2020. The mean blood pressure was recorded and annotated at various times such as immediately before the tracheal intubation. This time point was named as moment '5'. (NCT02483611)
Timeframe: This measure of average blood pressure was performed immediately before the tracheal intubation
| Intervention | mmHg (Median) |
|---|---|
| Group M | 62.50 |
| Group ML | 61.50 |
| Group C | 67.00 |
In the operating room, patients were cardiovascular, respiratory and body temperature monitored through the Dixtal 2020. The mean blood pressure was recorded and annotated at various times such as one minute after the tracheal intubation. This time point was named as moment '6'. (NCT02483611)
Timeframe: This measure of average blood pressure was performed one minute after the tracheal intubation
| Intervention | mmHg (Median) |
|---|---|
| Group M | 64.50 |
| Group ML | 64.00 |
| Group C | 69.00 |
In the operating room, patients were cardiovascular, respiratory and body temperature monitored through the Dixtal 2020. The mean blood pressure was recorded and annotated at various times such as 15 minutes after the traqueal intubation. This time point was named as moment '7a'. (NCT02483611)
Timeframe: This measure of average blood pressure was performed 15 minutes after the traqueal intubation
| Intervention | mmHg (Median) |
|---|---|
| Group M | 66.00 |
| Group ML | 61.50 |
| Group C | 69.00 |
In the operating room, patients were cardiovascular, respiratory and body temperature monitored through the Dixtal 2020. The mean blood pressure was recorded and annotated at various times such as 30 minutes after the traqueal intubation. This time point was named as moment '7b'. (NCT02483611)
Timeframe: This measure of average blood pressure was performed 30 minutes after the traqueal intubation
| Intervention | mmHg (Median) |
|---|---|
| Group M | 66.50 |
| Group ML | 63.50 |
| Group C | 68.00 |
In the operating room, patients were cardiovascular, respiratory and body temperature monitored through the Dixtal 2020. The mean blood pressure was recorded and annotated at various times such as 45 minutes after the traqueal intubation. This time point was named as moment '7c'. (NCT02483611)
Timeframe: This measure of average blood pressure was performed 45 minutes after the traqueal intubation
| Intervention | mmHg (Mean) |
|---|---|
| Group M | 69.25 |
| Group ML | 63.00 |
| Group C | 69.00 |
In the operating room, patients were cardiovascular, respiratory and body temperature monitored through the Dixtal 2020. The mean blood pressure was recorded and annotated at various times such as 60 minutes after the traqueal intubation. This time point was named as moment '7d'. (NCT02483611)
Timeframe: This measure of average blood pressure was performed 60 minutes after the traqueal intubation
| Intervention | mmHg (Median) |
|---|---|
| Group M | 68.00 |
| Group ML | 62.00 |
| Group C | 66.00 |
In the operating room, patients were cardiovascular, respiratory and body temperature monitored through the Dixtal 2020. The mean blood pressure was recorded and annotated at various times such as 75 minutes after the traqueal intubation. This time point was named as moment '7e'. (NCT02483611)
Timeframe: This measure of average blood pressure was performed 75 minutes after the traqueal intubation
| Intervention | mmHg (Median) |
|---|---|
| Group M | 68.00 |
| Group ML | 66.00 |
| Group C | 69.00 |
In the operating room, patients were cardiovascular, respiratory and body temperature monitored through the Dixtal 2020. The mean blood pressure was recorded and annotated at various times such as 90 minutes after the traqueal intubation. This time point was named as moment '7f'. (NCT02483611)
Timeframe: This measure of average blood pressure was performed 90 minutes after the traqueal intubation
| Intervention | mmHg (Median) |
|---|---|
| Group M | 64.00 |
| Group ML | 64.50 |
| Group C | 72.00 |
"The recovery index is the elapsed time between the T1 recovery =25% (Dur25%) and T1 =75% (Dur75%) after the infusion of cisatracurium.~This outcome meansure was presented in minutes." (NCT02483611)
Timeframe: Participants were followed during the anesthetic - surgical procedure, an average of 90 minutes
| Intervention | minutes (Mean) |
|---|---|
| Group M | 20.08 |
| Group ML | 20.26 |
| Group C | 14.53 |
"Spontaneous recovery is the elapsed time for the recovery of the TOF (T4 / T1) response to 90% of the original after infusion of cisatracurium.~This outcome measure was presented in minutes." (NCT02483611)
Timeframe: The participants were followed during the anesthetic - surgical procedure
| Intervention | minutes (Mean) |
|---|---|
| Group M | 120.20 |
| Group ML | 126.70 |
| Group C | 90.03 |
"The total duration is the elapsed time for T1 recovery of the response to reach 95% of the initial after the infusion of cisatracurium.~This outcome measure was presented in minutes." (NCT02483611)
Timeframe: Participants were followed during the anesthetic - surgical procedure, an average of 90 minutes
| Intervention | minutes (Mean) |
|---|---|
| Group M | 113.20 |
| Group ML | 120.10 |
| Group C | 88.19 |
18 reviews available for succinylcholine and Apnea
| Article | Year |
|---|---|
Personalized pediatric anesthesia and pain management: problem-based review.
Topics: Anesthesia; Anesthesiology; Apnea; Child; Child, Preschool; Humans; Malignant Hyperthermia; Pain; Pa | 2020 |
Pseudocholinesterase Deficiency: What the Proceduralist Needs to Know.
Topics: Anesthesia, General; Apnea; Butyrylcholinesterase; Dilatation; Endoscopy; Esophageal Achalasia; Huma | 2019 |
Butyrylcholinesterase deficiency and its clinical importance in anaesthesia: a systematic review.
Topics: Anesthesia; Apnea; Butyrylcholinesterase; Humans; Metabolism, Inborn Errors; Mivacurium; Neuromuscul | 2019 |
PharmGKB summary: succinylcholine pathway, pharmacokinetics/pharmacodynamics.
Topics: Apnea; Butyrylcholinesterase; Calcium Channels; Calcium Channels, L-Type; Humans; Hyperkalemia; Mali | 2015 |
Cholinesterase: phenotyping and genotyping.
Topics: Acetylcholinesterase; Amino Acid Substitution; Apnea; Butyrylcholinesterase; Cholinesterase Inhibito | 2004 |
Plasma cholinesterase variants and the anaesthetist.
Topics: Adult; Anesthesia; Apnea; Cholinesterases; Female; Gene Frequency; Genes; Genetic Variation; Genotyp | 1980 |
Anesthesia for cesarean section.
Topics: Anesthesia, Epidural; Anesthesia, General; Anesthesia, Intravenous; Anesthesia, Spinal; Anesthetics; | 1980 |
The plasma cholinesteerases: a new perspective.
Topics: Acetylcholinesterase; Anesthesia, General; Apnea; Cholinesterases; Dibucaine; Fluorides; Genes; Gene | 1981 |
Local anesthetic drugs: tissue and systemic toxicity.
Topics: Anesthesia, Conduction; Anesthetics, Local; Animals; Apnea; Arrhythmias, Cardiac; Barbiturates; Cent | 1981 |
[Genetically determined variations in drug response (author's transl)].
Topics: Acetyltransferases; Animals; Apnea; Butyrylcholinesterase; Cholinesterases; Genetic Variation; Gluco | 1975 |
Pharmacogenetics.
Topics: Analgesics; Anemia, Hemolytic; Anesthetics; Apnea; Bone Marrow Diseases; Child; Child, Preschool; Ch | 1972 |
Uses and limitations of enzyme tests.
Topics: Alcoholism; Apnea; Child; Clinical Enzyme Tests; Diagnosis, Differential; Female; Hepatitis A; Heter | 1974 |
Studies of aversive conditioning for alcoholics: a critical review of theory and research methodology.
Topics: Acoustic Stimulation; Alcohol Drinking; Alcoholism; Apnea; Aversive Therapy; Conditioning, Classical | 1974 |
Pharmacogenetics.
Topics: Acetyltransferases; Administration, Topical; Alleles; Analgesics; Anemia, Hemolytic; Anti-Inflammato | 1974 |
[Pharmacogenetic problems in anesthesia].
Topics: Anesthesia; Apnea; Cholinesterases; Female; Genetics, Medical; Humans; Hypothermia, Induced; Male; P | 1966 |
Pharmacogenetics. Cholinesterase variants and suxamethonium apnoea.
Topics: Alleles; Apnea; Cholinesterase Inhibitors; Cholinesterases; Dibucaine; Drug Hypersensitivity; Electr | 1968 |
[Cholinesterase. A survey with particular reference to inherited increase in sensitivity to suxamethonium].
Topics: Apnea; Blood Transfusion; Cholinesterases; Drug Hypersensitivity; Genes, Recessive; Humans; Metaboli | 1970 |
[Genetically dependent variability of drug effects].
Topics: Anemia, Hemolytic; Anesthesia, General; Anesthetics; Animals; Antipyrine; Apnea; Atropine; Body Temp | 1970 |
13 trials available for succinylcholine and Apnea
| Article | Year |
|---|---|
Rapid sequence induction with a "modified timing principle" of rocuronium provides excellent intubating conditions: A randomised trial.
Topics: Androstanols; Apnea; Humans; Intubation, Intratracheal; Neuromuscular Nondepolarizing Agents; Propof | 2022 |
Effect of suxamethonium vs rocuronium on onset of oxygen desaturation during apnoea following rapid sequence induction.
Topics: Adult; Androstanols; Anesthesia, General; Anesthetics, Intravenous; Anesthetics, Local; Apnea; Fasci | 2010 |
Desaturation following rapid sequence induction using succinylcholine vs. rocuronium in overweight patients.
Topics: Adult; Androstanols; Anesthesia, General; Apnea; Blood Gas Analysis; Body Mass Index; Endpoint Deter | 2011 |
Desaturation following rapid sequence induction using succinylcholine vs. rocuronium in overweight patients.
Topics: Adult; Androstanols; Anesthesia, General; Apnea; Blood Gas Analysis; Body Mass Index; Endpoint Deter | 2011 |
Desaturation following rapid sequence induction using succinylcholine vs. rocuronium in overweight patients.
Topics: Adult; Androstanols; Anesthesia, General; Apnea; Blood Gas Analysis; Body Mass Index; Endpoint Deter | 2011 |
Desaturation following rapid sequence induction using succinylcholine vs. rocuronium in overweight patients.
Topics: Adult; Androstanols; Anesthesia, General; Apnea; Blood Gas Analysis; Body Mass Index; Endpoint Deter | 2011 |
Succinylcholine dosage and apnea-induced hemoglobin desaturation in patients.
Topics: Adult; Anesthesia Recovery Period; Apnea; Body Mass Index; Diaphragm; Dose-Response Relationship, Dr | 2005 |
Tracheal intubating conditions and apnoea time after small-dose succinylcholine are not modified by the choice of induction agent.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anesthesia, General; Apnea; Dose-Response Relationship, | 2005 |
The effects of magnesium sulphate-pretreatment on suxamethonium-induced complications during induction of general endotracheal anaesthesia.
Topics: Adult; Anesthesia, General; Anesthetics; Apnea; Fasciculation; Female; Humans; Hyperkalemia; Intubat | 2007 |
Plasma cholinesterase and abnormal reaction to succinylcholine: twenty years' experience with the Danish Cholinesterase Research Unit.
Topics: Apnea; Butyrylcholinesterase; Cholinesterases; Denmark; Electric Stimulation; Female; Genes; Genetic | 1995 |
Study of the safe threshold of apneic period in children during anesthesia induction.
Topics: Age Factors; Anesthesia, Intravenous; Anesthetics, Intravenous; Apnea; Body Height; Body Weight; Bra | 1996 |
Effectiveness of continuous positive airway pressure to enhance pre-oxygenation in morbidly obese women.
Topics: Adult; Anesthesia, General; Apnea; Blood Pressure; Body Mass Index; Female; Heart Rate; Humans; Intu | 2001 |
A comparison of recovery times between Althesin and methohexitone following anaesthesia for electro-convulsive therapy.
Topics: Adult; Aged; Anesthesia, Intravenous; Anesthetics; Apnea; Clinical Trials as Topic; Drug Interaction | 1972 |
A clinical trial of apparatus for anaesthesia for domiciliary midwifery.
Topics: Adolescent; Adult; Anesthesia, Obstetrical; Apnea; Clinical Trials as Topic; Dreams; Female; Home Ca | 1973 |
[Pharmacogenetic reaction to succinyldicholine: therapy of prolonged apnea].
Topics: Adult; Anesthesia; Animals; Apnea; Child; Cholinesterases; Clinical Trials as Topic; Female; Humans; | 1967 |
The interaction of suxamethonium with propanidid and thiopentone.
Topics: Adult; Age Factors; Apnea; Female; Humans; Male; Middle Aged; Muscular Diseases; Pain; Propanidid; S | 1970 |
350 other studies available for succinylcholine and Apnea
| Article | Year |
|---|---|
A prolonged paralysis with succinylcholine in pseudocholinesterase deficiency: an undesired effect.
Topics: Apnea; Butyrylcholinesterase; Humans; Metabolism, Inborn Errors; Paralysis; Succinylcholine | 2022 |
Pseudocholinesterase Deficiency Considerations: A Case Study.
Topics: Apnea; Butyrylcholinesterase; Female; Humans; Metabolism, Inborn Errors; Mivacurium; Succinylcholine | 2020 |
Timing of blood sampling for butyrylcholinesterase phenotyping in patients with prolonged neuromuscular block after mivacurium or suxamethonium.
Topics: Apnea; Butyrylcholinesterase; Humans; Mivacurium; Neuromuscular Blockade; Succinylcholine | 2021 |
Prolonged apnea after ECT in organophosphorus poisoning - the need to redefine norms.
Topics: Apnea; Electroconvulsive Therapy; Female; Humans; Neuromuscular Depolarizing Agents; Organophosphate | 2021 |
Phenotype and genotype characteristics of 58 patients showing a prolonged effect of succinylcholine: A four-year experience.
Topics: Apnea; Genotype; Humans; Mutation; Phenotype; Succinylcholine | 2021 |
Prolonged paralysis in a child with organophosphate pesticide poisoning.
Topics: Apnea; Atropine; Butyrylcholinesterase; Critical Care; Emergency Medical Services; Follow-Up Studies | 2018 |
Reversal of succinylcholine induced apnea with an organophosphate scavenging recombinant butyrylcholinesterase.
Topics: Animals; Apnea; Butyrylcholinesterase; Catalysis; Guinea Pigs; Humans; Male; Mice; Recombinant Prote | 2013 |
Patient information sheet for plasma cholinesterase deficiency.
Topics: Apnea; Butyrylcholinesterase; Cholinesterases; Documentation; Drug Hypersensitivity; Follow-Up Studi | 2013 |
Rocuronium-sugammadex use in electroconvulsive therapy of patients with pseudocholinesterase enzyme deficiency.
Topics: Androstanols; Apnea; Butyrylcholinesterase; Contraindications; Electroconvulsive Therapy; gamma-Cycl | 2013 |
[Residual relaxant block due to pseudocholinesterase deficiency - First manifestation in an elderly patient].
Topics: Aged; Anesthesia Recovery Period; Anesthesia, General; Apnea; Butyrylcholinesterase; Humans; Intraop | 2014 |
Use of neuromuscular monitoring to detect prolonged effect of succinylcholine or mivacurium: three case reports.
Topics: Accelerometry; Aged; Antidotes; Apnea; Appendicitis; Butyrylcholinesterase; Cholecystectomy, Laparos | 2014 |
Allergic reaction to suxamethonium during emergency caesarean section and pseudocholinesterase deficiency in the same patient.
Topics: Anesthesia, Obstetrical; Apnea; Butyrylcholinesterase; Cesarean Section; Diagnosis, Differential; Dr | 2014 |
Characterization of a novel BCHE "silent" allele: point mutation (p.Val204Asp) causes loss of activity and prolonged apnea with suxamethonium.
Topics: Alleles; Apnea; Base Sequence; Biocatalysis; Butyrylcholinesterase; DNA Mutational Analysis; Family | 2014 |
Premature awakening and underuse of neuromuscular monitoring in a registry of patients with butyrylcholinesterase deficiency.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Apnea; Butyrylcholinesterase; Child; Child, Preschool; F | 2015 |
Prolonged Apnea During Modified Electroconvulsive Therapy in a Patient of Suicidal Attempt by Organophosphorus Poisoning: A Case Report.
Topics: Adult; Anesthesia, Intravenous; Anesthetics, Intravenous; Apnea; Bipolar Disorder; Humans; Male; Neu | 2016 |
[Prolonged neuromuscular block in a patient with butyrylcholinesterase deficiency].
Topics: Adolescent; Apnea; Butyrylcholinesterase; Humans; Male; Metabolism, Inborn Errors; Neuromuscular Dep | 2016 |
Fasciculations after succinylcholine and arterial oxygen tensions.
Topics: Apnea; Fasciculation; Humans; Oxygen; Rocuronium; Succinylcholine | 2016 |
Unknown Pseudocholinesterase Deficiency in a Patient Undergoing TIVA with Planned Motor Evoked Potential Monitoring: A Case Report.
Topics: Aged, 80 and over; Anesthesia, Intravenous; Apnea; Butyrylcholinesterase; Cervical Vertebrae; Diskec | 2016 |
Electroconvulsive Therapy Considerations for Transgendered Patients.
Topics: Adult; Androstanols; Apnea; Butyrylcholinesterase; Depressive Disorder, Treatment-Resistant; Drug In | 2017 |
The relation of plasma cholinesterases to response to clinical doses of succinylcholine.
Topics: Apnea; Cholinesterases; Dose-Response Relationship, Drug; Humans; Male; Neuromuscular Depolarizing A | 2008 |
General medicine and surgery for dental practitioners. Part 2--metabolic disorders.
Topics: Amyloidosis; Anesthetics, Local; Apnea; Carbohydrate Metabolism, Inborn Errors; Dental Care for Chro | 2010 |
Butyrylcholinesterase gene mutations in patients with prolonged apnea after succinylcholine for electroconvulsive therapy.
Topics: Adult; Aged; Anesthesia; Anesthesia Recovery Period; Apnea; Butyrylcholinesterase; Dose-Response Rel | 2011 |
Desaturation during rapid sequence induction of anaesthesia.
Topics: Androstanols; Apnea; Humans; Neuromuscular Depolarizing Agents; Neuromuscular Nondepolarizing Agents | 2010 |
Prolonged neuromuscular paralysis following rapid-sequence intubation with succinylcholine.
Topics: Apnea; Butyrylcholinesterase; Female; Humans; Intubation, Intratracheal; Metabolism, Inborn Errors; | 2011 |
[Apnea after general anesthesia for revision of uterus in parturient with K-variant of the butyrylcholinesterase enzyme (BChE)].
Topics: Adult; Anesthesia, General; Apnea; Butyrylcholinesterase; Female; Humans; Labor, Obstetric; Neuromus | 2012 |
Prolonged apnea following succinylcholine administration in undiagnosed acute organophosphate poisoning.
Topics: Acute Disease; Apnea; Diagnostic Errors; Dichlorvos; Food Contamination; Humans; Infant; Insecticide | 2002 |
Rapid identification of atypical variant of plasma butyrylcholinesterase by PCR.
Topics: Apnea; Butyrylcholinesterase; Female; Genetic Testing; Genetic Variation; Heterozygote; Homozygote; | 2002 |
[Emergency from anesthesia in small children. From laryngospasm to prolonged apnea].
Topics: Airway Obstruction; Anesthesia; Apnea; Butyrylcholinesterase; Child, Preschool; Emergency Medical Se | 2003 |
Assay using succinyldithiocholine as substrate: the method of choice for the measurement of cholinesterase catalytic activity in serum to diagnose succinyldicholine sensitivity.
Topics: Anesthetics, Local; Apnea; Butyrylthiocholine; Cariostatic Agents; Catalysis; Cholinesterase Inhibit | 2003 |
Fresh frozen plasma for succinylcholine apnoea--time to reconsider?
Topics: Adult; Apnea; Cholinesterases; Female; Humans; Neuromuscular Depolarizing Agents; Plasma; Succinylch | 2003 |
Butyrylcholinesterase (BCHE) genotyping for post-succinylcholine apnea in an Australian population.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anesthetics; Apnea; Australia; Butyrylcholinesterase; Ch | 2003 |
Prolonged apnoea following injection of succinyldicholine.
Topics: Apnea; Humans; Injections; Succinylcholine | 1953 |
Bronchial neoplasm with myasthenia; prolonged apnoea after administration of succinylcholine.
Topics: Apnea; Bronchial Neoplasms; Disease; Humans; Lung Neoplasms; Muscle Weakness; Muscles; Muscular Dise | 1953 |
[Case of prolonged apnea after succinylcholine administration].
Topics: Apnea; Delivery, Obstetric; Female; Humans; Jaundice; Obstetric Labor Complications; Pregnancy; Succ | 1953 |
Prolonged scoline apnoea treated by blood transfusion.
Topics: Apnea; Blood Transfusion; Humans; Succinylcholine | 1954 |
Nine hours' apnoea following succinylcholine.
Topics: Apnea; Humans; Succinylcholine | 1954 |
Suxamethonium sensitivity in health and disease; a clinical evaluation of pseudo-cholinesterase levels.
Topics: Apnea; Butyrylcholinesterase; Cholinesterases; Drug Hypersensitivity; Health; Humans; Metabolism, In | 1954 |
Prolonged apnoea after suxamethonium; a case study of pseudocholinesterase.
Topics: Apnea; Butyrylcholinesterase; Cholinesterases; Electroconvulsive Therapy; Humans; Succinylcholine | 1954 |
[Case of prolonged apnea due to celocurin].
Topics: Apnea; Humans; Succinylcholine | 1954 |
[Apnea caused by succinylcholine and its relation to serum cholinesterase].
Topics: Apnea; Blood; Cholinesterases; Humans; Succinylcholine | 1954 |
Prolonged apnoea following suxamethonium chloride.
Topics: Apnea; Humans; Succinylcholine | 1954 |
Prolonged apnoea after suxamethonium in man.
Topics: Apnea; Humans; Male; Succinylcholine | 1955 |
Dual action of suxamethonium chloride.
Topics: Apnea; Humans; Neostigmine; Succinylcholine | 1956 |
Prolonged succinylcholine apnoea reversed by prostigmin.
Topics: Apnea; Humans; Neostigmine; Succinylcholine | 1956 |
[beta-Diethylamino-ethyl-diphenylpropyl acetate (SKF 525 A); potentiation of the effects of succinylcholine; contribution to the study of the mechanism of prolonged succinylcholine-induced apnea].
Topics: Acetates; Apnea; Fatty Acids; Humans; Proadifen; Succinylcholine | 1956 |
[beta-Diethylamino-ethyl-diphenylpropyl acetate (SKF 525 A); potentiation of the effects of succinylcholine; contribution to the study of the mechanism of prolonged succinylcholine-induced apnea].
Topics: Acetates; Apnea; Fatty Acids; Humans; Proadifen; Succinylcholine | 1956 |
[beta-Diethylamino-ethyl-diphenylpropyl acetate (SKF 525 A); potentiation of the effects of succinylcholine; contribution to the study of the mechanism of prolonged succinylcholine-induced apnea].
Topics: Acetates; Apnea; Fatty Acids; Humans; Proadifen; Succinylcholine | 1956 |
[beta-Diethylamino-ethyl-diphenylpropyl acetate (SKF 525 A); potentiation of the effects of succinylcholine; contribution to the study of the mechanism of prolonged succinylcholine-induced apnea].
Topics: Acetates; Apnea; Fatty Acids; Humans; Proadifen; Succinylcholine | 1956 |
The relation between dose of succinylcholine and duration of apnea in man.
Topics: Apnea; Humans; Male; Succinylcholine | 1957 |
Persistent apnoea associated with succinylcholine chloride.
Topics: Apnea; Humans; Succinylcholine | 1957 |
[Duration apnea due to succinylcholine in relation to administration of plasma].
Topics: Apnea; Blood Transfusion; Humans; Plasma; Succinylcholine | 1958 |
Sensitivity to suxamethonium; apnoea in two brothers.
Topics: Apnea; Humans; Male; Siblings; Succinylcholine | 1958 |
Modified ECT using succinylcholine followed by prolonged apnea.
Topics: Apnea; Electroconvulsive Therapy; Humans; Succinylcholine | 1959 |
Prolonged apnoea following E.C.T. modified by suxethonium (brevidil E).
Topics: Apnea; Convulsive Therapy; Electroconvulsive Therapy; Humans; Muscle Relaxants, Central; Succinylcho | 1959 |
[Findings on prolonged apnea caused by succinylcholine: effect of the nature of the anesthetic].
Topics: Anesthesia; Anesthetics; Apnea; Humans; Succinylcholine | 1959 |
Prolonged apnoea after suxamethonium increased intracranial pressure.
Topics: Anesthesia; Apnea; Humans; Intracranial Hypertension; Intracranial Pressure; Succinylcholine | 1961 |
[Prolonged apnea after succinylcholine chloride].
Topics: Apnea; Humans; Succinylcholine | 1961 |
[Prolonged apnea caused by succinylcholine and treatment by transfusion].
Topics: Apnea; Blood Transfusion; Humans; Platelet Transfusion; Succinylcholine | 1961 |
[On prolonged apnea from succinyl-choline].
Topics: Apnea; Humans; Succinylcholine | 1961 |
Prolonged apnoea following the use of suxamethonium. A case presenting some unusual features.
Topics: Anesthesia; Apnea; Cardiovascular Agents; Humans; Iatrogenic Disease; Muscle Relaxants, Central; Suc | 1960 |
[Succinyl-bis-choline chloride drop infusion for the prevention of prolonged apnoe or paralysis].
Topics: Apnea; Biomedical Research; Choline; Humans; Paralysis; Succinylcholine; Surgical Procedures, Operat | 1959 |
[Late recurarization during the use of Dilitin].
Topics: Anesthesia; Anesthesia, General; Anesthesiology; Apnea; Humans; Succinylcholine | 1961 |
Prolonged apnoea due to suxamethonium.
Topics: Apnea; Humans; Succinylcholine | 1961 |
[Practical importance of plasma cholinesterase determination and its atypical behavior in relation to succinylbischoline].
Topics: Apnea; Cholinesterases; Humans; Succinylcholine | 1962 |
Prolonged apnea following the use of succinylcholine.
Topics: Apnea; Humans; Parathion; Succinylcholine | 1963 |
Prolonged respiratory depression caused by drug combinations. Muscle relaxants and intraperitoneal antibiotics as etiologic agents.
Topics: Anti-Bacterial Agents; Apnea; Drug Combinations; Neomycin; Respiratory Insufficiency; Streptomycin; | 1963 |
[On 3 cases of apnea caused by succinylcholine].
Topics: Adjuvants, Anesthesia; Apnea; Calcium; Calcium, Dietary; Cholinesterases; Humans; Succinylcholine | 1963 |
Prolonged apnoea after intermittent intramuscular suxamethonium in a neonate.
Topics: Apnea; Humans; Infant; Infant, Newborn; Infant, Newborn, Diseases; Succinylcholine | 1962 |
An investigation of a new aversive conditioning treatment for alcoholism.
Topics: Alcoholism; Apnea; Conditioning, Classical; Conditioning, Psychological; Humans; Reflex; Succinylcho | 1963 |
[On the side-effects of succinyl-bis-choline, especially on prolonged apnea. Critical remarks based on 1200 intubation anesthetics with succinvl-bis-choline].
Topics: Anesthetics; Apnea; Choline; Humans; Intubation; Succinylcholine | 1963 |
[On the problem of prolonged relaxation with short-acting muscle relaxants].
Topics: Apnea; Cardiovascular Agents; Humans; Succinylcholine | 1963 |
[STUDIES ON THE DIFFERENTIATION OF THE TYPE OF NEUROMUSCULAR BLOCK].
Topics: Anesthesia; Anesthesia, General; Anesthesiology; Animals; Apnea; Decamethonium Compounds; Dogs; Elec | 1962 |
THE MISMANAGEMENT OF SUXAMETHONIUM APNOEA.
Topics: Apnea; Humans; Succinylcholine; Toxicology | 1963 |
FAMILIAL SENSITIVITY TO SUXAMETHONIUM DUE TO ATYPICAL PSEUDOCHOLINESTERASE.
Topics: Apnea; Butyrylcholinesterase; Cholinesterases; Genetics, Medical; Geriatrics; Humans; Succinylcholin | 1964 |
SUXAMETHONIUM APNOEA.
Topics: Apnea; Succinylcholine | 1964 |
SUXAMETHONIUM SENSITIVITY.
Topics: Apnea; Blood; Butyrylcholinesterase; Cholinesterases; Drug Hypersensitivity; Fluorides; Genetics, Me | 1964 |
[GENETICS AND BIOCHEMISTRY OF PSEUDOCHOLINESTERASES].
Topics: Apnea; Biochemical Phenomena; Biochemistry; Biological Evolution; Butyrylcholinesterase; Cholinester | 1963 |
CARDIAC ARREST (WITH APNOEA) AFTER E.C.T.
Topics: Apnea; Electroconvulsive Therapy; Heart Arrest; Humans; Muscle Relaxants, Central; Succinylcholine; | 1964 |
[EXPERIMENTAL STUDIES ON A FORM OF RESTING TREMOR IN THE EXTREMITIES OF HEALTHY DOGS].
Topics: Apnea; Dogs; Electrocardiography; Electroencephalography; Electromyography; Extremities; Heart Arres | 1964 |
APNEA DUE TO INHERITANCE OF ATYPICAL PSEUDOCHOLINESTERASE.
Topics: Abscess; Anesthesia; Anesthesia, General; Anesthesiology; Apnea; Butyrylcholinesterase; Cholinestera | 1964 |
[ON A CASE OF PROLONGED APNEA CAUSED BY SUCCINYLCHOLINE].
Topics: Adjuvants, Anesthesia; Anesthesia; Anesthesia, General; Anesthesiology; Apnea; Cerebral Angiography; | 1964 |
CLINICAL STUDIES OF INDUCTION AGENTS. XI. THE INFLUENCE OF SOME INTRAVENOUS ANAESTHETICS ON THE RESPIRATORY EFFECTS AND SEQUELAE OF SUXAMETHONIUM.
Topics: Anesthesia; Anesthesia, Intravenous; Anesthetics; Anesthetics, Intravenous; Apnea; Barbiturates; Hyp | 1964 |
A COMPLICATION OF THE USE OF SUXAMETHONIUM "EXTENSION" BY TETRAHYDROAMINACRINE.
Topics: Adolescent; Apnea; Appendectomy; Atropine; Bradycardia; Central Nervous System Stimulants; Humans; H | 1964 |
ENZYMES AND DRUG SENSITIVITY. THE GENETICS OF SERUM CHOLINESTERASE 'DEFICIENCY' IN RELATION TO SUXAMETHONIUM APNOEA.
Topics: Apnea; Blood; Cholinesterases; Drug Tolerance; Genetics, Medical; Humans; Metabolism, Inborn Errors; | 1964 |
[OBSERVATIONS ON THE USE OF MUSCLE RELAXANTS IN PATIENTS WITH ADRENAL CORTEX HYPERFUNCTION].
Topics: Adrenal Cortex; Adrenalectomy; Adrenocortical Hyperfunction; Anesthesia; Apnea; Cushing Syndrome; Hu | 1964 |
PROBLEMS IN PAEDIATRIC ANAESTHESIA.
Topics: Anesthesia; Anesthesiology; Apnea; Arrhythmias, Cardiac; Bradycardia; Child; Humans; Hypothermia; In | 1964 |
PHARMACOGENETICS IN PRE-ECT MEDICATION.
Topics: Antidotes; Apnea; Blood; Blood Transfusion; Cholinesterases; Electroconvulsive Therapy; Genetics, Me | 1964 |
THE PSEUDOCHOLINESTERASE VARIANTS: ESTERASE LEVELS AND INCREASED RESISTANCE TO FLUORIDE.
Topics: Apnea; Biochemical Phenomena; Blood; Butyrylcholinesterase; Cholinesterases; Esterases; Fluorides; G | 1964 |
ON NOMENCLATURE OF PSEUDOCHOLINESTERASE POLYMORPHISM.
Topics: Apnea; Blood; Butyrylcholinesterase; Cholinesterases; Genetics, Medical; Humans; Polymorphism, Genet | 1964 |
[ON 2 CASES OF PROLONGED APNEA DUE TO SUCCINYLCHOLINE].
Topics: Apnea; Succinylcholine; Toxicology | 1964 |
CARBON DIOXIDE ELIMINATION DURING INSUFFLATION ANAESTHESIA.
Topics: Anesthesia, General; Anesthesia, Inhalation; Anesthesiology; Apnea; Bronchoscopy; Carbon Dioxide; Hu | 1965 |
PROCEDURE FOR DETECTING A TYPICAL SERUM CHOLINESTERASE USING O-NITROPHENYLBUTYRATE AS SUBSTRATE.
Topics: Apnea; Biomedical Research; Blood Chemical Analysis; Cholinesterases; Genetics, Medical; Humans; Mol | 1965 |
DETECTION OF ATYPICAL CHOLINESTERASE BY ELECTROPHORESIS.
Topics: Apnea; Blood; Chemistry Techniques, Analytical; Cholinesterases; Drug Hypersensitivity; Electrophore | 1965 |
[ON THE USE OF SUCCINYLCHOLINE AS A MUSCLE RELAXANT].
Topics: Apnea; Child; Humans; Infant; Muscle Relaxants, Central; Succinylcholine; Toxicology | 1965 |
Suxamethonium apnoea in an infant; expression of familial pseudocholinesterase deficiency in three generations.
Topics: Apnea; Bis-Trimethylammonium Compounds; Butyrylcholinesterase; Child; Cholinesterases; Humans; Infan | 1960 |
[Studies on the duration of apnea after succinylcholine in ventilation with intermittent positive pressure or with positive-negative pressure with reference to the Hering-Breuer reflex].
Topics: Anesthesia; Anesthesiology; Apnea; Humans; Reflex; Respiration; Succinylcholine | 1960 |
Plasma cholinesterase and the duration of succinylcholine-induced apnea.
Topics: Apnea; Cholinesterases; Succinylcholine | 1960 |
Prolonged apnea after administration of succinylcholine.
Topics: Apnea; Humans; Succinylcholine | 1960 |
[On prolonged apnea caused by the use of Listenol].
Topics: Apnea; Humans; Succinylcholine | 1962 |
Apnoea due to suxamethonium associated with familial pseudocholinesterase deficiency.
Topics: Apnea; Butyrylcholinesterase; Cholinesterases; Humans; Metabolism, Inborn Errors; Muscular Diseases; | 1962 |
Prolonged succinylcholine apnoea resulting from acquired deficiency of plasma cholinesterase.
Topics: Aged; Antineoplastic Agents, Alkylating; Apnea; Cholinesterases; Cyclophosphamide; Humans; Male; Neu | 2003 |
The management of succinylcholine apnoea.
Topics: Apnea; Blood-Borne Pathogens; Humans; Neuromuscular Depolarizing Agents; Succinylcholine | 2003 |
Fresh frozen plasma for succinylcholine apnoea.
Topics: Apnea; Humans; Neuromuscular Depolarizing Agents; Plasma; Succinylcholine | 2004 |
Accidental administration of succinylcholine for the treatment of hypotension in a labouring parturient.
Topics: Adult; Apnea; Color; Drug Compounding; Drug Labeling; Female; Humans; Hypotension; Labor, Obstetric; | 2004 |
[Prolonged succinylcholine-induced apnoea associated with cholinesterase silent plasma variant].
Topics: Aged; Apnea; Butyrylcholinesterase; Cholinesterases; Humans; Male; Neuromuscular Depolarizing Agents | 2005 |
Use of remifentanil for tracheal intubation for caesarean section in a patient with suxamethonium apnoea.
Topics: Adult; Analgesics, Opioid; Anesthesia, General; Anesthesia, Obstetrical; Apnea; Cesarean Section; Co | 2005 |
[Accidental use of suxamethonium for general anesthesia in a patient with hereditary hypocholinesterasemia that was not recognized preoperatively].
Topics: Adult; Anesthesia, General; Apnea; Cesarean Section; Cholinesterases; Chronic Disease; Colectomy; Co | 2006 |
Molecular basis of succinylcholine sensitivity in a prairie Hutterite kindred and genetic characterization of the region containing the BCHE gene.
Topics: Apnea; Butyrylcholinesterase; Canada; Dibucaine; Ethnicity; Female; Genetics, Population; Humans; Ma | 2007 |
Determination of butyrylcholinesterase (BChE) phenotypes to predict the risk of prolonged apnea in persons receiving succinylcholine in the healthy population of western Iran.
Topics: Adult; Apnea; Butyrylcholinesterase; Female; Humans; Iran; Male; Risk; Succinylcholine | 2007 |
Testing for suxamethonium apnoea.
Topics: Apnea; Humans; Neuromuscular Depolarizing Agents; Succinylcholine | 2007 |
[Prolonged apnea after succinyldicholine].
Topics: Apnea; Cholinesterases; Humans; Succinylcholine | 1966 |
Effect of carbon dioxide on the cortical seizure threshold to lidocaine.
Topics: Amygdala; Animals; Apnea; Blood Pressure Determination; Brain; Carbon Dioxide; Cats; Cerebral Cortex | 1967 |
Prolonged postoperative apnea with pseudocholinesterase deficiency.
Topics: Adult; Anesthesia, General; Apnea; Bronchography; Cholinesterases; Deficiency Diseases; Female; Huma | 1967 |
Evaluation of an aversive technique as a treatment for alcoholism. Controlled trial with succinylcholine-induced apnea.
Topics: Alcoholism; Apnea; Conditioning, Classical; Conditioning, Psychological; Follow-Up Studies; Humans; | 1967 |
The clinical use of muscle relaxants.
Topics: Anesthesia; Apnea; Decamethonium Compounds; Drug Synergism; Gallamine Triethiodide; Humans; Muscles; | 1967 |
Potentiation of succinylcholine by organophosphate compounds in horses.
Topics: Animals; Anthelmintics; Apnea; Cholinesterases; Drug Synergism; Gluconates; Horse Diseases; Horses; | 1967 |
Pre-oxygenation and thiopentone-suxamethonium induction.
Topics: Adjuvants, Anesthesia; Adult; Aged; Anesthesia, Endotracheal; Apnea; Carbon Dioxide; Female; Humans; | 1967 |
Suxamethonium apnoea.
Topics: Apnea; Humans; Succinylcholine | 1967 |
A review of succinylcholine-induced apnea.
Topics: Apnea; Cholinesterases; Drug Interactions; Female; Humans; Postoperative Complications; Pregnancy; R | 1982 |
A new succinylcholine-based assay of plasma cholinesterase.
Topics: Alcohol Oxidoreductases; Apnea; Choline; Cholinesterase Inhibitors; Cholinesterases; Humans; Hydroge | 1984 |
Frequencies of atypical serum cholinesterase in a mixed population of northeastern Brazil.
Topics: Alleles; Apnea; Black People; Brazil; Cholinesterases; Female; Gene Frequency; Humans; Indians, Sout | 1984 |
A family with the silent cholinesterase gene.
Topics: Adult; Alleles; Anesthesia, Endotracheal; Apnea; Cholinesterases; Female; Heterozygote; Humans; Meta | 1983 |
Succinylcholine apnoea: attempted reversal with anticholinesterases.
Topics: Adult; Apnea; Cholinesterase Inhibitors; Cholinesterases; Female; Heterozygote; Humans; Succinylchol | 1983 |
Scoline apnoea.
Topics: Aged; Apnea; Female; Humans; Succinylcholine | 1984 |
Prolonged apnea after orthognathic surgery due to atypical cholinesterase.
Topics: Adult; Anesthesia, Dental; Anesthesia, Intravenous; Apnea; Cholinesterases; Female; Humans; Mandible | 1981 |
Eye drops and apnea.
Topics: Anesthesia; Apnea; Drug Interactions; Echothiophate Iodide; Humans; Ophthalmic Solutions; Respiratio | 1983 |
Heterozygotes for atypical cholinesterase.
Topics: Adolescent; Adult; Aged; Apnea; Cholinesterases; Electroconvulsive Therapy; Female; Heterozygote; Hu | 1983 |
Prolonged neuromuscular blockade following succinylcholine in a patient homozygous for the silent gene.
Topics: Adult; Apnea; Cholinesterases; Electric Stimulation; Female; Genotype; Homozygote; Humans; Muscle Co | 1983 |
Suxamethonium apnoea associated with pregnancy and liver dysfunction in a treated cretin.
Topics: Adult; Anesthesia, Obstetrical; Apnea; Cesarean Section; Cholinesterases; Congenital Hypothyroidism; | 1983 |
Prolonged succinylcholine-induced apnea caused by atypical cholinesterase: report of case.
Topics: Adult; Apnea; Cholinesterase Inhibitors; Cholinesterases; Facial Injuries; Humans; Male; Mandibular | 1980 |
Apnoea following suxamethonium: the genetic study of four generations of a family.
Topics: Adult; Apnea; Child; Cholinesterases; Female; Humans; Male; Middle Aged; Pedigree; Succinylcholine | 1982 |
Routine induction of anaesthesia with thiopental and suxamethonium: apnoea without ventilation?
Topics: Anesthesia, General; Apnea; Humans; Intubation, Intratracheal; Middle Aged; Oxygen Inhalation Therap | 1982 |
[Succinylcholine apnea].
Topics: Apnea; Cholinesterases; Humans; Succinylcholine | 1982 |
[Succinylcholinic apnoea, study of a thirteen-member family (author's transl)].
Topics: Adjuvants, Anesthesia; Adolescent; Adult; Apnea; Child; Child, Preschool; Cholinesterases; Female; F | 1982 |
Prolonged postoperative apnea complicating gynecologic surgery; atypical cholinesterase and myasthenia gravis.
Topics: Adult; Apnea; Cholinesterases; Female; Genital Diseases, Female; Humans; Infant, Newborn; Middle Age | 1982 |
Reduced plasma cholinesterase following haemodilutional cardiopulmonary bypass.
Topics: Aged; Apnea; Cardiopulmonary Bypass; Cholinesterases; Hemodilution; Humans; Male; Succinylcholine | 1982 |
Prolonged postoperative succinylcholine-induced apnea with pseudocholinesterase deficiency.
Topics: Adult; Apnea; Butyrylcholinesterase; Cholinesterases; Female; Humans; Postoperative Complications; S | 1982 |
Prolonged apnoea after suxamethonium in a Malaysian patient due to silent plasma cholinesterase--first case report.
Topics: Apnea; Cholinesterases; Humans; Malaysia; Male; Middle Aged; Phenotype; Succinylcholine | 1982 |
Suxamethonium sensitivity -- yet another case.
Topics: Adult; Apnea; Cholinesterases; Drug Hypersensitivity; Female; Humans; Male; Succinylcholine | 1982 |
Plasma cholinesterase activity in bank blood.
Topics: Adult; Anesthesia, General; Apnea; Blood Banks; Blood Preservation; Blood Transfusion; Cholinesteras | 1980 |
A family segregating for E1j and E1k at cholinesterase locus 1.
Topics: Adolescent; Alleles; Apnea; Female; Humans; Male; Pedigree; Phenotype; Succinylcholine | 1980 |
[Blood and plasma transfusion in the treatment of prolonged succinylcholine apnea].
Topics: Adult; Aged; Apnea; Blood Transfusion; Butyrylcholinesterase; Humans; Middle Aged; Plasma; Succinylc | 1981 |
Haemodynamic and neurological responses of ventilated and apnoeic calves to succinyldicholine.
Topics: Animals; Apnea; Catecholamines; Cattle; Cattle Diseases; Electroencephalography; Hemodynamics; Male; | 1981 |
Patient sensitivity to suxamethonium due to abnormal enzyme--a case report.
Topics: Adult; Anesthesia, Obstetrical; Apnea; Butyrylcholinesterase; Cesarean Section; Cholinesterases; Fem | 1981 |
Pseudocholinesterase levels and rates of chloroprocaine hydrolysis in patients receiving adequate doses of phospholine iodide.
Topics: Apnea; Butyrylcholinesterase; Cholinesterases; Echothiophate Iodide; Humans; Procaine; Succinylcholi | 1980 |
Suxamethonium apnoea associated with plasmaphoresis.
Topics: Adult; Anesthesia, Obstetrical; Apnea; Cesarean Section; Cholinesterases; Female; Humans; Plasmapher | 1980 |
Propanidid--suxamethonium apnea in bilharzial patients.
Topics: Adolescent; Adult; Anesthesia; Apnea; Cholinesterases; Drug Synergism; Female; Humans; Liver Disease | 1980 |
[A rare case of silent cholinesterase genetic variant (author's transl)].
Topics: Adolescent; Alleles; Anesthesia, General; Apnea; Cholinesterase Inhibitors; Cholinesterases; Heteroz | 1980 |
Plasma cholinesterase changes during pregnancy. Their interpretation as a cause of suxamethonium-induced apnoea.
Topics: Adolescent; Adult; Apnea; Cholinesterases; Female; Genotype; Humans; Postpartum Period; Pregnancy; P | 1980 |
Correlation of succinylcholine duration of action with plasma cholinesterase activity in subjects with the genotypically normal enzyme.
Topics: Adolescent; Adult; Aged; Apnea; Cholinesterases; Female; Humans; Male; Middle Aged; Neuromuscular Bl | 1980 |
Plasma cholinesterase deficiency in a neonate: a follow-up.
Topics: Apnea; Child, Preschool; Cholinesterases; Dibucaine; Female; Follow-Up Studies; Humans; Infant, Newb | 1995 |
Plasma cholinesterase activity in infants.
Topics: Apnea; Cholinesterases; Humans; Infant, Newborn; Neuromuscular Blocking Agents; Succinylcholine | 1994 |
Suxamethonium apnoea and the isolated leg.
Topics: Adult; Anesthesia, General; Apnea; Butyrylcholinesterase; Electric Stimulation; Genotype; Humans; Kn | 1994 |
Plasma cholinesterase deficiency in a premature neonate.
Topics: Anesthesia, Intravenous; Apnea; Cholinesterases; Humans; Infant, Newborn; Infant, Premature; Infant, | 1994 |
Sedation for non-invasive procedures: a potential hazard.
Topics: Aged; Aged, 80 and over; Apnea; Conscious Sedation; Female; Humans; Medication Errors; Pacemaker, Ar | 1994 |
Suxamethonium-induced prolonged apnoea in a premature neonate.
Topics: Anesthesia, Intravenous; Apnea; Cerebrospinal Fluid Shunts; Cholinesterases; Homozygote; Humans; Hyd | 1994 |
Suxamethonium in the deadspace of an adult's indwelling intravenous cannula.
Topics: Adult; Apnea; Catheters, Indwelling; Fasciculation; Humans; Male; Respiratory Dead Space; Succinylch | 1993 |
Fresh frozen plasma and edrophonium in a patient with a plasma cholinesterase deficiency.
Topics: Adult; Apnea; Cholinesterases; Edrophonium; Female; Humans; Monitoring, Physiologic; Neuromuscular J | 1993 |
Plasma cholinesterase deficiency in a neonate.
Topics: Apnea; Cholinesterases; Humans; Infant, Newborn; Injections, Intravenous; Succinylcholine; Time Fact | 1993 |
Respiratory arrest in two children following postoperative flushing of suxamethonium from the deadspace of intravenous cannulae.
Topics: Apnea; Catheterization; Child, Preschool; Humans; Male; Neuromuscular Depolarizing Agents; Postopera | 1996 |
[Prolonged apnea after suxamethonium administration during staphylococcal toxic shock].
Topics: Adult; Apnea; Cholinesterases; Humans; Male; Neuromuscular Depolarizing Agents; Shock, Septic; Staph | 1996 |
[Succinylcholine apnea in a patient homozygotic for atypical cholinesterase gene].
Topics: Acetylcholinesterase; Adult; Apnea; Homozygote; Humans; Male; Mutation; Neuromuscular Blocking Agent | 1997 |
[Prolonged curarization with suxamethonium in a four-week old infant].
Topics: Apnea; Cholinesterases; Genotype; Humans; Infant, Newborn; Intraoperative Complications; Male; Neuro | 1998 |
Critical hemoglobin desaturation can be delayed by apneic diffusion oxygenation.
Topics: Anesthesia, General; Apnea; Diffusion; Hemoglobins; Humans; Insufflation; Neuromuscular Depolarizing | 1999 |
Suxamethonium and mivacurium sensitivity from pregnancy-induced plasma cholinesterase deficiency.
Topics: Adult; Apnea; Cholinesterases; Female; Humans; Isoquinolines; Mivacurium; Neuromuscular Depolarizing | 1998 |
An explanation for the different inhibitory characteristics of human serum butyrylcholinesterase phenotypes deriving from inhibition of atypical heterozygotes.
Topics: Apnea; Butyrylcholinesterase; Carbamates; Cholinesterase Inhibitors; Dibucaine; Genetic Carrier Scre | 1999 |
[Pharmacogenic postoperative apnea. Bambuterol and succinylcholine].
Topics: Aged; Aged, 80 and over; Apnea; Bronchodilator Agents; Drug Interactions; Humans; Male; Neuromuscula | 1999 |
A case of pseudocholinesterase deficiency in the neonate.
Topics: Apnea; Butyrylcholinesterase; Humans; Infant, Newborn; Male; Metabolism, Inborn Errors; Neuromuscula | 1999 |
Acquired pseudocholinesterase deficiency after high-dose cyclophosphamide.
Topics: Adrenal Gland Neoplasms; Apnea; Butyrylcholinesterase; Child, Preschool; Cyclophosphamide; Dose-Resp | 1999 |
Emergency caesarean section and suxamethonium apnoea.
Topics: Adult; Anesthesia, Obstetrical; Apnea; Cesarean Section; Cholinesterases; Contraindications; Drug Hy | 1998 |
Domestic swine model for the assessment of chemical warfare agent-anesthetic interactions: some effects of sulfur mustard.
Topics: Anesthesia, General; Anesthetics; Animals; Apnea; Chemical Warfare; Disease Models, Animal; Drug Eva | 2000 |
Hemoglobin desaturation after succinylcholine-induced apnea: a study of the recovery of spontaneous ventilation in healthy volunteers.
Topics: Adolescent; Adult; Apnea; Female; Hemoglobins; Humans; Male; Neuromuscular Depolarizing Agents; Oxyg | 2001 |
The intubating dose of succinylcholine.
Topics: Anesthesia; Apnea; Humans; Neuromuscular Depolarizing Agents; Succinylcholine | 2002 |
The safety of rapid sequence induction.
Topics: Anesthesia; Apnea; Hemoglobins; Humans; Neuromuscular Depolarizing Agents; Succinylcholine | 2002 |
Naturally occurring mutation, Asp70his, in human butyrylcholinesterase.
Topics: Amino Acid Substitution; Apnea; Asian People; Aspartic Acid; Black People; Butyrylcholinesterase; Hi | 2002 |
[Plasma cholinesterase variations as a result of prolonged neuromuscular blockade. Review and problems encountered in two cases of prolonged neuromuscular blockade after muscle relaxation with succinylcholine as compared to mivacurium].
Topics: Apnea; Cholinesterases; Humans; Isoquinolines; Male; Middle Aged; Mivacurium; Neuromuscular Depolari | 2002 |
Assessment of a diagnostic dip-stick for assaying plasma or serum pseudocholinesterase activity.
Topics: Apnea; Blood Chemical Analysis; Butyrylcholinesterase; Carbamates; Cholinesterase Inhibitors; Cholin | 1978 |
Scientific Review No. 5. Assay of cholinesterase in clinical chemistry.
Topics: Acetylcholinesterase; Animals; Apnea; Buffers; Chemistry, Clinical; Cholinesterase Inhibitors; Choli | 1979 |
[A case of succinylcholine apnea. Identification of genetic variants].
Topics: Apnea; Cholinesterases; Female; Genetic Variation; Humans; Pedigree; Succinylcholine | 1979 |
[A spectrophotometric method for the determination of serum cholinesterase variants with succinyl choline as substrate (author's transl)].
Topics: Anesthesia; Animals; Apnea; Choline; Cholinesterase Inhibitors; Cholinesterases; Cytochrome c Group; | 1975 |
Prolonged apnea following trimethaphan and succinylcholine.
Topics: Adjuvants, Anesthesia; Adult; Anesthesia, Obstetrical; Apnea; Cholinesterases; Female; Humans; Injec | 1979 |
Serum cholinesterase activity in burned patients. II: anaesthesia, suxamethonium and hyperkalaemia.
Topics: Adolescent; Adult; Aged; Anesthesia; Apnea; Burns; Carbon Dioxide; Child; Cholinesterases; Electroca | 1975 |
Pseudocholinesterase variation.
Topics: Apnea; Butyrylcholinesterase; Cholinesterases; Female; Genetic Carrier Screening; Genetic Variation; | 1978 |
Prolonged apnea of an oral surgery patient after administration of succinylcholine.
Topics: Adolescent; Anesthesia, Dental; Anesthesia, General; Apnea; Butyrylcholinesterase; Cholinesterase In | 1979 |
[Increase of anesthetic hazards through the use of modern anthelmintics in the horse].
Topics: Anesthesia; Animals; Anthelmintics; Apnea; Drug Interactions; Horse Diseases; Horses; Succinylcholin | 1979 |
Succinylcholine-induced apnea.
Topics: Apnea; Butyrylcholinesterase; Humans; Succinylcholine | 1979 |
Abnormal enzyme phenotype (E1a E1f): normal response to succinylcholine.
Topics: Adolescent; Apnea; Cholinesterases; Heterozygote; Humans; Male; Phenotype; Succinylcholine; Temperat | 1979 |
Succinylcholine sensitivity in a Nova Scotia family.
Topics: Adolescent; Adult; Anesthesia; Apnea; Cholinesterases; Female; Genotype; Homozygote; Humans; Male; P | 1978 |
Hazards of succinylcholine administration during electrotherapy.
Topics: Aged; Anti-Bacterial Agents; Apnea; Arrhythmias, Cardiac; Cholinesterase Inhibitors; Cholinesterases | 1978 |
[Current evalution of the test for detecting atypical cholinesterase].
Topics: Adult; Apnea; Child; Cholinesterases; Female; Humans; Male; Middle Aged; Pedigree; Succinylcholine | 1978 |
Prolonged apnoea after suxamethonium: an analysis of the first 225 cases reported to the Danish Cholinesterase Research Unit.
Topics: Adolescent; Adult; Aged; Apnea; Child; Child, Preschool; Cholinesterases; Female; Genotype; Humans; | 1978 |
Succinylcholine-prolonged apnea associated with clindamycin and abnormal liver function tests.
Topics: Adolescent; Apnea; Clindamycin; Female; Humans; Liver Function Tests; Schizophrenia; Succinylcholine | 1977 |
The use of serum cholinesterase in succinylcholine apnoea.
Topics: Adolescent; Adult; Apnea; Child; Cholinesterases; Female; Humans; Male; Middle Aged; Phenotype; Succ | 1977 |
Prolonged apnoea due to suxamethonium in Chinese.
Topics: Adult; Anesthesia, Intravenous; Apnea; Butyrylcholinesterase; China; Humans; Male; Succinylcholine | 1977 |
A Danish cholinesterase research unit.
Topics: Apnea; Cholinesterases; Denmark; Dibucaine; Female; Genetic Variation; Genotype; Humans; Male; Pedig | 1977 |
Suxamethonium apnoea terminated with commercial serumcholinesterase.
Topics: Adjuvants, Anesthesia; Apnea; Cholinesterases; Humans; Injections, Intravenous; Male; Middle Aged; S | 1976 |
[A Danish cholinesterase card index].
Topics: Apnea; Cholinesterases; Denmark; Genotype; Humans; Registries; Succinylcholine | 1976 |
[Succinyldicholin sensitivity resulting from genetically determined serumcholinesterase variants].
Topics: Alleles; Apnea; Cholinesterases; Drug Hypersensitivity; Female; Genotype; Homozygote; Humans; Male; | 1976 |
Hypersensitivity to suxamethonium in a Suffolk family.
Topics: Adult; Apnea; Cholinesterases; Drug Hypersensitivity; Female; Homozygote; Humans; Pedigree; Succinyl | 1976 |
Survey of local anesthetic toxicity in the families of patients with atypical plasma cholinesterase.
Topics: Anesthetics, Local; Apnea; Benzoylcholine; Cholinesterases; Dibucaine; Heterozygote; Homozygote; Hum | 1975 |
Succinylcholine-induced apnoea.
Topics: Anesthesia, Dental; Apnea; Child, Preschool; Humans; Male; Succinylcholine | 1976 |
Letter: criticism of a selected method: propionylthiocholinesterase.
Topics: Apnea; Choline; Cholinesterases; Drug Hypersensitivity; Heterozygote; Humans; Phenotype; Propionates | 1975 |
[Case of protracted apnea due to succinylcholine (duration: 7 hours)].
Topics: Aged; Apnea; Female; Humans; Succinylcholine; Time Factors | 1975 |
Response of the newborn to succinlycholine injection in homozygotic atypical mothers.
Topics: Adult; Anesthesia, Intravenous; Anesthesia, Obstetrical; Apnea; Cesarean Section; Cholinesterases; D | 1975 |
[Familial examinations for the presence of atypical cholinesterase].
Topics: Adolescent; Anesthesia, General; Apnea; Appendectomy; Child, Preschool; Cholinesterase Inhibitors; C | 1975 |
Incidence of suxamethonium apnoea in patients undergoing E.C.T.
Topics: Apnea; Cholinesterases; Humans; Phenotype; Succinylcholine | 1975 |
Suxamethonium sensitivity and segregation of human serum cholinesterase variants at locus, Ch1, among twelve British families.
Topics: Apnea; Cholinesterases; Drug Hypersensitivity; Female; Genetic Variation; Genotype; Humans; Male; Su | 1975 |
Central neural stimulation of respiration in unanesthetized decerebrate cats.
Topics: Animals; Apnea; Brain; Carbon Dioxide; Carotid Sinus; Cats; Decerebrate State; Gallamine Triethiodid | 1976 |
A note on suxamethonium sensitivity and serum cholinesterase variants.
Topics: Apnea; Cholinesterases; Drug Hypersensitivity; Genetic Variation; Humans; Succinylcholine | 1976 |
Plasma cholinesterase variants - an unexpectedly high incidence of the silent allele.
Topics: Adolescent; Adult; Alleles; Apnea; Butyrylcholinesterase; Child; Child, Preschool; Cholinesterases; | 1976 |
Reversal of prolonged suxamethonium apnoea.
Topics: Apnea; Blood Transfusion; Cholinesterases; Humans; Infant; Plasma; Succinylcholine | 1992 |
Succinylcholine-induced prolonged apnea in a 3-week-old newborn: treatment with human plasma cholinesterase.
Topics: Apnea; Cholinesterases; Genotype; Halothane; Humans; Infant, Newborn; Male; Succinylcholine | 1992 |
[Succinylcholine-induced prolonged apnea and hyperthermia in a patient with organophosphate insecticide poisoning].
Topics: Adult; Apnea; Fever; Humans; Insecticides; Male; Organophosphorus Compounds; Succinylcholine | 1991 |
Reversal of prolonged suxamethonium apnoea with fresh frozen plasma in a 6-week-old infant.
Topics: Apnea; Cholinesterases; Homozygote; Humans; Infant; Male; Pedigree; Plasma; Succinylcholine; Time Fa | 1991 |
Suxamethonium in bunged cannulae.
Topics: Apnea; Catheterization, Peripheral; Child; Equipment Design; Equipment Safety; Humans; Injections, I | 1991 |
Scoline apnoea: a relatively common problem.
Topics: Adult; Anesthesia, Dental; Anesthesia, General; Apnea; Dental Care for Disabled; Humans; Male; Succi | 1990 |
[Prolonged action of relaxants of the succinyldicholine group in carriers of atypical forms of serum cholinesterase].
Topics: Adult; Anesthesia, Endotracheal; Apnea; Appendicitis; Cholinesterases; Delayed-Action Preparations; | 1990 |
Pre-eclampsia, dural tap and suxamethonium apnoea.
Topics: Adult; Anesthesia, Epidural; Anesthesia, Intravenous; Anesthesia, Obstetrical; Apnea; Female; Humans | 1990 |
Is there a use for stabilised human serum in the treatment of Scoline apnoea? A case report.
Topics: Adult; Apnea; Blood Transfusion; Cholinesterases; Female; Humans; Succinylcholine | 1990 |
Prolonged succinylcholine-induced paralysis in organophosphate insecticide poisoning.
Topics: Apnea; Child, Preschool; Chlorpyrifos; Cholinesterases; Female; Humans; Paralysis; Pralidoxime Compo | 1987 |
[Prolonged apnea after suxamethonium related to congenital abnormality of plasma pseudocholinesterase].
Topics: Anesthesia, General; Apnea; Butyrylcholinesterase; Child; Cholinesterases; Humans; Male; Pedigree; P | 1989 |
Automated determination of cholinesterase activity in plasma and erythrocytes by flow-injection analysis, and application to identify subjects sensitive to succinylcholine.
Topics: Adult; Aging; Anesthesia; Apnea; Autoanalysis; Cholinesterases; Erythrocytes; Female; Humans; Male; | 1989 |
Prolonged suxamethonium-induced neuromuscular block associated with organophosphate poisoning.
Topics: Apnea; Child, Preschool; Humans; Intraoperative Complications; Larynx; Male; Organophosphate Poisoni | 1989 |
Effect of plasma cholinesterase activity on the duration of action of succinylcholine in patients with genotypically normal enzyme.
Topics: Adult; Apnea; Cholinesterases; Genotype; Humans; Liver Transplantation; Neuromuscular Junction; Succ | 1988 |
An alternative approach to the prevention of succinyldicholine-induced apnoea.
Topics: Apnea; Butyrylcholinesterase; Cholinesterases; Humans; Methods; Succinylcholine | 1988 |
Prolonged suxamethonium-induced neuromuscular blockade associated with organophosphate poisoning.
Topics: Adult; Apnea; Cholinesterases; Humans; Malathion; Male; Succinylcholine; Time Factors | 1988 |
[Phenotype of plasma cholinesterase in prolonged apnea and sensitivity to succinylcholine].
Topics: Anesthesia, General; Apnea; Cholinesterase Inhibitors; Dibucaine; Family; Female; Humans; Phenotype; | 1987 |
Suxamethonium apnoea in a 4-month-old twin.
Topics: Apnea; Cholinesterases; Diseases in Twins; Genotype; Humans; Infant; Intraoperative Complications; M | 1987 |
Is succinyldicholine the substrate of choice for the measurement of cholinesterase activity?
Topics: Adult; Apnea; Cholinesterases; Heterozygote; Humans; Male; Middle Aged; Succinylcholine; Thiocholine | 1986 |
Pesticide poisoning, succinylcholine-induced apnea, and pseudocholinesterase.
Topics: Apnea; Butyrylcholinesterase; Cholinesterase Inhibitors; Cholinesterases; Dibucaine; Humans; Pestici | 1986 |
Prolonged neuromuscular blockade following suxamethonium in a patient with a normal genotype.
Topics: Apnea; Child; Cholinesterases; Female; Genotype; Humans; Postoperative Complications; Succinylcholin | 1986 |
Combined electroconvulsive and drug therapy.
Topics: Anesthesia; Apnea; Atropine; Bipolar Disorder; Combined Modality Therapy; Depressive Disorder; Elect | 1985 |
Suxamethonium apnoea.
Topics: Anesthesia; Apnea; Cholinesterase Inhibitors; Cholinesterases; Drug Synergism; Humans; Liver; Metabo | 1973 |
Blood-gas tensions during apnoea in hyperbaric oxygen.
Topics: Acidosis; Acidosis, Respiratory; Animals; Apnea; Asphyxia Neonatorum; Blood Gas Analysis; Humans; Hy | 1966 |
[A case of prolonged apnea in Huntington's chorea].
Topics: Anesthesia; Apnea; Female; Humans; Huntington Disease; Middle Aged; Succinylcholine; Surgical Proced | 1968 |
Abnormal responses to muscle relaxants in a patient with Von Recklinghausen's disease (multiple neurofibromatosis).
Topics: Adult; Androstanes; Apnea; Humans; Male; Neurofibromatosis 1; Neuromuscular Nondepolarizing Agents; | 1970 |
Plasma cholinesterase deficiency. A possible complication during anesthesia.
Topics: Adolescent; Anesthesia, General; Apnea; Cholinesterases; Endoscopy; Female; Genotype; Humans; Intuba | 1972 |
[Cholinesterase and Huntington's chorea].
Topics: Anesthesia; Apnea; Cholinesterases; Female; Humans; Huntington Disease; Middle Aged; Succinylcholine | 1971 |
Suxamethonium--a review. II. Neuromuscular blocking properties.
Topics: Acid-Base Equilibrium; Action Potentials; Adult; Anesthetics; Apnea; Decamethonium Compounds; Dose-R | 1973 |
Effects of intravenous and intra-arterial procaine and lidocaine on neuromuscular transmission in man.
Topics: Apnea; Drug Synergism; Humans; Injections, Intra-Arterial; Injections, Intravenous; Lidocaine; Muscl | 1969 |
Succinylcholine--prolonged apnoea and some dangers.
Topics: Acetylcholine; Acetylcholinesterase; Adult; Alleles; Apnea; Autonomic Nerve Block; Biological Transp | 1970 |
Succinylcholine-hexafluorenium combination for muscular relaxation: a reappraisal.
Topics: Adolescent; Adult; Aged; Apnea; Blood Pressure; Child; Drug Synergism; Female; Ganglionic Blockers; | 1968 |
[Decreasing of suxamethonium induced apnea with Akrinor].
Topics: Adjuvants, Anesthesia; Apnea; Central Nervous System Stimulants; Humans; Succinylcholine; Time Facto | 1969 |
Letter: Death after E.C.T.
Topics: Amitriptyline; Apnea; Cholinesterases; Electroconvulsive Therapy; Humans; Succinylcholine | 1974 |
Aetiology of prolonged apnoea after suxamethonium.
Topics: Adolescent; Adult; Aged; Apnea; Catalysis; Child; Child, Preschool; Cholinesterases; Dibucaine; Drug | 1974 |
[Plasma cholinesterase (CHE, pseudocholinesterase), its importance in liver diseases and prolonged succinyldicholine-induced apnea].
Topics: Apnea; Cholinesterases; Humans; Immunoglobulins; Liver; Liver Diseases; Succinylcholine | 1974 |
Abnormal response to a muscle relaxant. Report of three cases.
Topics: Apnea; Cholinesterases; Metabolism, Inborn Errors; Succinylcholine | 1973 |
A case study: Anectine and apnea.
Topics: Adult; Anesthesia, Inhalation; Apnea; Child; Child, Preschool; Cholinesterases; Drug Hypersensitivit | 1974 |
Cyclophosphamide, cholinesterase and anaesthesia.
Topics: Adult; Anesthesia, General; Apnea; Blood Transfusion; Cholinesterases; Cyclophosphamide; Female; Hum | 1972 |
Sensitivity to succinylcholine.
Topics: Apnea; Cholinesterases; Humans; Succinylcholine | 1973 |
Relationship between suxamethonium apnoea, serum cholinesterase activity and inhibitor numbers.
Topics: Apnea; Cholinesterase Inhibitors; Cholinesterases; Heterozygote; Homozygote; Humans; Phenotype; Succ | 1974 |
Effects of bitemporal electrical stimulation on the duration of suxamethonium apnoea in man.
Topics: Adult; Anesthesia, Intravenous; Apnea; Atropine; Electroconvulsive Therapy; Female; Humans; Male; Ox | 1974 |
A rare constellation of serum cholinesterase genetic variants.
Topics: Adolescent; Adult; Apnea; Cholinesterases; Erythrocytes; Female; Genetic Variation; Heterozygote; HL | 1972 |
Apnea and atypical pseudocholinesterase.
Topics: Adult; Apnea; Cholinesterases; Female; Humans; Male; Metabolism, Inborn Errors; Succinylcholine | 1973 |
Scoline apnoea.
Topics: Anesthesia, General; Apnea; Cholinesterases; Humans; Male; Metabolism, Inborn Errors; Middle Aged; S | 1973 |
Scoline apnoea.
Topics: Apnea; Humans; Methods; Succinylcholine | 1973 |
[The application of serum cholinesterase in prolonged apnoea following suxamethonium].
Topics: Anesthesia, Intravenous; Apnea; Cholinesterases; Humans; Male; Middle Aged; Succinylcholine; Thiopen | 1973 |
Apnea in an atypical-fluoride resistant (E1aE1f) heterozygote for serum cholinesterase.
Topics: Adjuvants, Anesthesia; Anesthesia, Endotracheal; Apnea; Child, Preschool; Cholinesterases; Drug Resi | 1973 |
Succinylcholine and pseudocholinesterase.
Topics: Apnea; Cholinesterases; Humans; Succinylcholine | 1973 |
Prolonged apnea in an infant following the use of succinylcholine.
Topics: Anesthesia, Inhalation; Apnea; Cholinesterases; Genotype; Humans; Infant; Male; Pedigree; Pyloric St | 1973 |
Apneic anesthesia for microlaryngeal surgery.
Topics: Anesthesia, Intravenous; Apnea; Carbon Dioxide; Humans; Hydrogen-Ion Concentration; Laryngoscopy; La | 1973 |
[Long-term succinylcholine apnea. Genetic aspects].
Topics: Apnea; Humans; Pedigree; Succinylcholine; Time Factors | 1974 |
Dangers of succinylcholine in anesthesia.
Topics: Anesthesia; Apnea; Cholinesterases; Clinical Enzyme Tests; Dose-Response Relationship, Drug; Humans; | 1974 |
Atypical plasma cholinesterase, succinylcholine, and prolonged apnea.
Topics: Aged; Anesthesia; Apnea; Cholinesterases; Dibucaine; Female; Humans; Succinylcholine; Time Factors | 1974 |
Half-life of human serum cholinesterase following blood transfusion.
Topics: Adult; Albumins; Apnea; Blood Proteins; Blood Transfusion; Cholinesterases; Female; Half-Life; Human | 1974 |
Carbon dioxide elimination during bronchoscopy. A comparison of two alternative general anaesthetic techniques.
Topics: Analysis of Variance; Anesthesia, General; Apnea; Arrhythmias, Cardiac; Blood Specimen Collection; B | 1968 |
Qualitative defects of pseudocholinesterase activity.
Topics: Adolescent; Adult; Aged; Apnea; Child; Cholinesterases; Clinical Enzyme Tests; Cyclophosphamide; Dib | 1967 |
Genetics of esterases in man.
Topics: Acetylcholinesterase; Adult; Apnea; Asian People; Biotransformation; Black People; Blood Protein Ele | 1968 |
Therapy of prolonged apnea after suxamthonium with purified pseudocholinesterase. New data on kinetics of the hydrolysis of succinyldicholine and succinylmonocholine and further data on N-acetyltransferase-polymorphism.
Topics: Alleles; Ammonium Chloride; Aniline Compounds; Animals; Apnea; Carbon Isotopes; Cholinesterases; Coe | 1968 |
Aspects of suxamethonium hydrolysis in man and animals.
Topics: Acetylcholine; Acetylcholinesterase; Alleles; Animals; Apnea; Cats; Cholinesterase Inhibitors; Choli | 1970 |
Suxamethonium sensitivity.
Topics: Apnea; Carbon Isotopes; Cholinesterase Inhibitors; Cholinesterases; Drug Hypersensitivity; Drug Stab | 1971 |
Serum cholinesterase, pregnancy and suxamethonium.
Topics: Anesthesia, Obstetrical; Apnea; Cesarean Section; Cholinesterases; Female; Humans; Infant, Newborn; | 1972 |
Suxamethonium apnoea in a child.
Topics: Apnea; Child, Preschool; Female; Humans; Succinylcholine | 1972 |
Detection of patients with low serum cholinesterase activity: inadequacy of "Acholest" method.
Topics: Apnea; Blood Protein Disorders; Choline; Cholinesterases; Heterozygote; Homozygote; Humans; Methods; | 1972 |
Effect of propranolol hydrochloride on the neuromuscular blocking action of d-tubocurarine and succinylcholine in man.
Topics: Apnea; Drug Antagonism; Humans; Neuromuscular Junction; Propranolol; Succinylcholine; Tubocurarine | 1972 |
Succinylcholine dosage based on lean body mass.
Topics: Adolescent; Adult; Aged; Anesthesia, General; Apnea; Body Weight; Female; Halothane; Humans; Intubat | 1972 |
An original approach to the diagnosis of scoline-induced apnoea.
Topics: Apnea; Cholinesterases; Dibucaine; Heterozygote; Homozygote; Humans; Hydrogen-Ion Concentration; Hyd | 1972 |
[Pseudocholinesterase].
Topics: Anesthesia; Apnea; Cholinesterase Inhibitors; Cholinesterases; Enzyme Activation; Genotype; Humans; | 1972 |
A rapid measurement of functional residual capacity in the paralyzed dog.
Topics: Animals; Apnea; Dogs; Lung; Methods; Paresis; Plethysmography, Whole Body; Pulmonary Ventilation; Re | 1972 |
Deaths with dental anaesthetics.
Topics: Anesthesia, Dental; Apnea; Brain Diseases; Child; Female; Humans; Hypotension; Posture; Succinylchol | 1971 |
[Data on serum cholinesterase activity in cases of prolonged apnea due to succinylcholine].
Topics: Adult; Anesthesia; Apnea; Appendectomy; Child, Preschool; Cholecystectomy; Cholinesterases; Female; | 1971 |
Organophosphate-induced complications during anesthetic management in the horse.
Topics: Anesthesia; Animals; Apnea; Arrhythmias, Cardiac; Blood Pressure; Carbon Dioxide; Carbon Disulfide; | 1971 |
[Cholinesterase and prolonged apnea due to succinylcholine].
Topics: Adult; Anesthesia; Apnea; Cholinesterases; Female; Humans; Hydrolysis; Hypercapnia; Male; Middle Age | 1971 |
Malignant hyperthermia during anaesthesia. A neurophysiological and neuropathological follow-up study of a patient and his family.
Topics: Action Potentials; Adolescent; Adult; Anesthesia, General; Apnea; Biopsy; Central Nervous System; Ch | 1971 |
Suxamethonium sensitivity.
Topics: Anesthesia, General; Apnea; Blood Transfusion; Child; Cholinesterases; Dibucaine; Drug Hypersensitiv | 1967 |
Possible interaction between muscle relaxants and the kallikrein-trypsin inactivator "Trasylol". Report of three cases.
Topics: Adult; Anesthesia, General; Apnea; Aprotinin; Drug Synergism; Female; Gastrointestinal Hemorrhage; H | 1966 |
The influence of the kallikrein-trypsin inactivator Trasylol on the serum cholinesterase.
Topics: Adolescent; Adult; Aged; Apnea; Aprotinin; Cholinesterase Inhibitors; Cholinesterases; Female; Human | 1968 |
[Prolonged succinyl apnea as an indication of alkylphosphate poisoning].
Topics: Adult; Anesthesia, General; Apnea; Cerebral Ventriculography; Cholinesterase Inhibitors; Humans; Ins | 1968 |
Influence of aprotinin (Trasylol) on the action of suxamethonium.
Topics: Apnea; Aprotinin; Cholinesterase Inhibitors; Cholinesterases; Humans; Injections, Intravenous; Respi | 1970 |
Variation in cardiac output with acid-base changes in the anesthetized dog.
Topics: Acidosis; Acidosis, Respiratory; Animals; Apnea; Blood Circulation; Blood Gas Analysis; Carbon Dioxi | 1965 |
[Succinycholine apnea].
Topics: Apnea; Female; Humans; Middle Aged; Succinylcholine | 1969 |
Prolonged suxamethonium-induced apnoea as a sign of organophosphate poisoning.
Topics: Adult; Apnea; Humans; Male; Parathion; Phosphates; Poisoning; Succinylcholine; Suicide | 1969 |
A new test for cholinesterase (ChE) prior to electro shock therapy.
Topics: Apnea; Cholinesterases; Electroconvulsive Therapy; Humans; Methods; Succinylcholine | 1969 |
[The activity of respiratory neurons in the absence of respiratory movements].
Topics: Animals; Apnea; Cats; Electrophysiology; Lung; Medulla Oblongata; Neurons, Afferent; Respiration; Re | 1969 |
A simple test for abnormal pseudocholinesterase.
Topics: Anesthesia; Apnea; Cholinesterases; Female; Humans; Middle Aged; Succinylcholine | 1970 |
[Apnea due to succinyldicholine: study of a French-Canadian population].
Topics: Adolescent; Adult; Aged; Apnea; Canada; Child; Choline; Cholinesterases; Female; Humans; Male; Middl | 1970 |
The neuromuscular blocking properties of the antimalarial agent, bis((chloro-7"-quinolyl-4")amino-2'-propyl)-1,4-piperazine.
Topics: Acetylcholine; Animals; Antimalarials; Apnea; Calcium; Chloroquine; Diaphragm; Electric Stimulation; | 1970 |
The effects of anesthesia and 100 per cent oxygen on the functional residual capacity of the lungs.
Topics: Adult; Apnea; Female; Halothane; Helium; Humans; Lung; Male; Middle Aged; Oxygen; Respiration; Rest; | 1970 |
A family study of atypical plasma cholinesterase activity.
Topics: Adult; Apnea; Child; Cholinesterases; Clinical Enzyme Tests; Diagnosis, Differential; Dibucaine; Fem | 1970 |
An appraisal of tacrine-extended suxamethonium.
Topics: Acridines; Adult; Aged; Anesthesia, General; Apnea; Appendectomy; Cholinesterases; Drug Synergism; H | 1970 |
The temperature activity relationships of serum cholinesterases.
Topics: Apnea; Cholinesterase Inhibitors; Cholinesterases; Dibucaine; Fluorides; Humans; Phenotype; Succinyl | 1970 |
Initial experiences with the Cholinesterase Research Unit.
Topics: Apnea; Child; Cholinesterases; Dibucaine; Female; Fluorides; Genotype; Heterozygote; Humans; Male; M | 1970 |
[Depolarizing relaxants (succinylcholine) in children].
Topics: Apnea; Child; Child, Preschool; Humans; Infant; Infant, Newborn; Injections, Intramuscular; Injectio | 1970 |
Genetics--the anaesthetist at risk.
Topics: Apnea; Barbiturates; Dibucaine; Female; Fever; Humans; Hydrocarbons, Halogenated; Male; Nitrous Oxid | 1970 |
The effects of other drugs on the stimulation of laryngospasm in the cat: atropine; thiopentone, suxamethonium; local analgesics.
Topics: Anesthetics, Local; Animals; Apnea; Atropine; Cats; Laryngismus; Larynx; Lidocaine; Respiration; Suc | 1971 |
Plasma cholinesterase activity in newborns and infants.
Topics: Apnea; Cholinesterase Inhibitors; Cholinesterases; Dibucaine; Female; Halothane; Heart Block; Humans | 1971 |
[The enzymatic degradation of succinic acid dicholine ester in the human lung].
Topics: Acetylcholinesterase; Adolescent; Adult; Age Factors; Aged; Apnea; Blood Proteins; Cholinesterases; | 1967 |
[Prolonged apnea induced by succinylcholine].
Topics: Anesthesia; Apnea; Humans; Succinylcholine | 1967 |
[Clinical study of prolonged apnea due to succinylcholine during gynecologic interventions].
Topics: Anesthesia, Endotracheal; Apnea; Female; Humans; Leiomyoma; Middle Aged; Succinylcholine; Uterine Ce | 1967 |
[Respiratory insufficiency presumably due to K deficiency after succinylcholine administration--effect of potassium asparaginate].
Topics: Anesthesia, Intravenous; Apnea; Asparagine; Female; Humans; Male; Middle Aged; Potassium; Potassium | 1967 |
[Research on serum cholinesterase activity in subjects with prolonged apnea caused by succinylcholine].
Topics: Adult; Aged; Apnea; Cholinesterases; Female; Humans; Male; Middle Aged; Succinylcholine | 1967 |
Atypical cholinesterase gene E1a: rarity in Negroes and most Orientals.
Topics: Alleles; Apnea; Asian People; Black or African American; Cholinesterases; Gene Frequency; Genes, Dom | 1968 |
Punishment of alcohol consumption by apneic paralysis.
Topics: Adult; Alcoholic Beverages; Alcoholism; Apnea; Avoidance Learning; Behavior Therapy; Extinction, Psy | 1968 |
Dynamics of oxygen stores changes following an alteration in ventilation.
Topics: Animals; Apnea; Arteries; Asphyxia; Carbon Dioxide; Cardiac Output; Dogs; Models, Biological; Muscle | 1968 |
Suxamethonium apnoea.
Topics: Apnea; Blood Specimen Collection; Cholinesterases; Humans; Succinylcholine | 1968 |
Atypical pseudocholinesterase activity: a review and presentation of two cases.
Topics: Aged; Apnea; Cholinesterase Inhibitors; Cholinesterases; Dibucaine; Female; Genetics, Medical; Human | 1968 |
An additional pseudocholinesterase phenotype occurring in suxamethonium apnoea.
Topics: Apnea; Chlorides; Cholinesterases; Clinical Enzyme Tests; Dibucaine; Fluorides; Humans; Middle Aged; | 1968 |
Suxamethonium and intraocular pressure.
Topics: Adult; Age Factors; Anesthesia, Intravenous; Apnea; Child; Child, Preschool; Humans; Infant; Intraoc | 1968 |
Glaucoma associated with suxamethonium apnoea.
Topics: Anesthesia, General; Apnea; Glaucoma; Humans; Intraocular Pressure; Male; Middle Aged; Succinylcholi | 1968 |
[Atypical pseudochlolinesterase and prolonged apnea induced by succinyldicholine: report of 2 cases].
Topics: Adolescent; Apnea; Child; Cholinesterases; Drug Hypersensitivity; Female; Humans; Male; Succinylchol | 1968 |
The drug modification of ECT. II. Succinylcholine dosage.
Topics: Adult; Apnea; Arrhythmias, Cardiac; Atropine; Body Weight; Electroconvulsive Therapy; Electrokymogra | 1968 |
Abnormal reaction to procaine and succinylcholine in a patient with inherited atypical plasma cholinesterase: case report.
Topics: Abdomen; Adjuvants, Anesthesia; Adult; Anesthesia, Local; Apnea; Cholinesterases; Drug Hypersensitiv | 1968 |
Suxamethonium apnoea.
Topics: Apnea; Cholinesterases; Humans; Succinylcholine | 1968 |
[Prolonged apnea caused by succinylcholine in obstetrical operations].
Topics: Adult; Anesthesia, Obstetrical; Apnea; Female; Humans; Pregnancy; Succinylcholine | 1968 |
Sexamethonium and serum cholinesterase. Comparative studies in vitro and in vivo on the catabolism of suxamethonium.
Topics: Apnea; Blood Protein Electrophoresis; Cholinesterase Inhibitors; Cholinesterases; Female; Humans; Mi | 1968 |
[Treatment of the genetically determined hypersensitivity to succinylcholine].
Topics: Apnea; Cholinesterases; Drug Hypersensitivity; Humans; Succinylcholine | 1968 |
[Shortening of suxamethonium-induced apnea by Akrinor].
Topics: Adolescent; Adult; Anesthesia, Endotracheal; Apnea; Appendectomy; Blood Pressure; Female; Humans; In | 1968 |
[Prolonged apnea following to administration of succinylcholine].
Topics: Adult; Apnea; Cholinesterases; Head and Neck Neoplasms; Humans; Lipoma; Male; Postoperative Complica | 1968 |
[On a case of prolonged apnea after administration of succinylcholine in a patient with fibrocystic disease of the pancreas or mucoviscidosis].
Topics: Adolescent; Anesthesia; Apnea; Appendectomy; Appendicitis; Child; Cystic Fibrosis; Female; Humans; M | 1968 |
Serum cholinesterase deficiency in renal failure.
Topics: Acute Kidney Injury; Anesthesia, General; Apnea; Cholinesterases; Deficiency Diseases; Humans; Kidne | 1969 |
Low serum pseudocholinesterase levels complicating treatment with phenelzine.
Topics: Adult; Apnea; Cholinesterases; Electroconvulsive Therapy; Female; Humans; Middle Aged; Phenelzine; S | 1969 |
[Studies on enzymes in human blood. X. Contribution to succinylcholine cleavability and its possible relationship to atypical serum esterases].
Topics: Acetylcholinesterase; Apnea; Blood Chemical Analysis; Humans; In Vitro Techniques; Succinylcholine | 1964 |
Evaluation of intraperitoneal neomycin: effect of respiration in dogs under anesthesia.
Topics: Anesthesia, Inhalation; Animals; Apnea; Calcium Chloride; Curare; Cyclopropanes; Dogs; Ethyl Ethers; | 1965 |
[Incidence of atypical pseudocholinesterase in the Bantu population of the Congo].
Topics: Apnea; Black or African American; Black People; Cholinesterases; Congo; Humans; In Vitro Techniques; | 1965 |
[Prolonged apnea due to atypical pseudocholinesterase].
Topics: Anesthesia, General; Apnea; Child; Cholinesterases; Cyanosis; Female; Genetics, Medical; Humans; Mus | 1965 |
[2 cases of prolonged apnea following administration of succinylcholine].
Topics: Adult; Apnea; Female; Humans; Succinylcholine | 1965 |
[Succinylcholine-induced apnea and familial cholinesterase deficiency].
Topics: Adult; Apnea; Cholinesterases; Humans; In Vitro Techniques; Male; Metabolic Diseases; Succinylcholin | 1965 |
[Resuscitative electric stimulation in prolonged apnea caused by electroshock in succinylcholine anesthesia].
Topics: Apnea; Electric Countershock; Electroconvulsive Therapy; Humans; Succinylcholine | 1965 |
[Experimental investigations on the enzymatic reduction of C14 labeled succinyldicholine].
Topics: Animals; Apnea; Carbon Isotopes; Enzymes; Humans; In Vitro Techniques; Injections, Intravenous; Para | 1965 |
[Clinical study of succinylcholine on prolonged apnea].
Topics: Abdomen; Adult; Aged; Apnea; Blood; Cholinesterases; Humans; Middle Aged; Succinylcholine | 1965 |
[Serum cholinesterase. Its significance in pulmonary diseases and bronchology].
Topics: Apnea; Blood; Cholinesterases; Humans; Lung Diseases; Lung Neoplasms; Succinylcholine; Tuberculosis, | 1965 |
Four families segregating for the silent gene for serum cholinesterase.
Topics: Adult; Apnea; Appendectomy; Child; Cholinesterases; Dibucaine; Enzymes; Female; Genes; Humans; Pulmo | 1965 |
A silent pseudocholinesterase gene. Marked suxamethonium sensitivity in a person heterozygous for the atypical and silent pseudocholinesterase genes.
Topics: Apnea; Blood Chemical Analysis; Cholinesterases; Dibucaine; Enzymes; Fluorides; Genes; Humans; Middl | 1965 |
Tendon reflexes as a guide to the safe use of succinylcholine in medicine.
Topics: Apnea; Blood; Cholinesterases; Depression; Electroconvulsive Therapy; Humans; Neural Conduction; Neu | 1966 |
Prolongation of the action of suxamethonium. A clinical investigation.
Topics: Acridines; Anesthesia, Endotracheal; Apnea; Blood Chemical Analysis; Cholinesterases; Dibucaine; Enz | 1966 |
Prolonged apnoea after suxamethonium injection associated with eye drops containing an anticholinesterase agent.
Topics: Aged; Anesthesia, Endotracheal; Apnea; Cholinesterase Inhibitors; Echothiophate Iodide; Female; Glau | 1966 |
Suxamethonium apnoea. A study of eighteen cases.
Topics: Adolescent; Adult; Aged; Anesthesia, General; Apnea; Child; Child, Preschool; Cholinesterases; Dibuc | 1966 |
A study of the pseudocholinesterase in 78 cases of apnoea following suxamethonium.
Topics: Apnea; Chlorides; Cholinesterases; Dibucaine; Drug Hypersensitivity; Fluorides; Genes; Humans; Succi | 1966 |
A clinical and biochemical approach to cholinesterase problems in anesthesia.
Topics: Anesthesia; Apnea; Cholinesterases; Succinylcholine | 1966 |
Aversion treatment of alcoholics by succinylcholine-induced apneic paralysis.
Topics: Adult; Alcoholism; Apnea; Conditioning, Operant; Conditioning, Psychological; Female; Humans; Male; | 1966 |
[Hyperpyrexia during general anaesthesia: a case report].
Topics: Adult; Anesthesia, General; Apnea; Bicarbonates; Decamethonium Compounds; Fever; Heart Massage; Huma | 1966 |
[Prolonged apnea caused by atypical pseudocholinesterase].
Topics: Adolescent; Anesthesia, General; Apnea; Appendectomy; Cholinesterases; Female; Homozygote; Humans; M | 1966 |
[On bronchoscopy in general anesthesia].
Topics: Acidosis, Respiratory; Adult; Aged; Anesthesia, General; Apnea; Bronchiectasis; Bronchoscopy; Carbon | 1966 |